Aether Global Innovations (AETHF) 20-F 4 Nov 24 2023 FY Annual report (foreign) Financial data

Document And Entity Information

Document And Entity Information	12 Months Ended
	Nov. 30, 2023 shares
Entity Addresses [Line Items]
Entity Registrant Name	AETHER GLOBAL INNOVATIONS CORP.
Entity Central Index Key	0001639142
Document Type	20-F
Document Period End Date	Nov. 30, 2023
Current Fiscal Year End Date	--11-30
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2023
Amendment Flag	false
Document Registration Statement	false
Document Annual Report	true
Document Transition Report	false
Entity Common Stock Shares Outstanding	105,504,461
Entity Incorporation, State or Country Code	Z4
Entity Address, Address Line One	Suite 700 - 1199 West Hastings Street
Entity Address, City or Town	Vancouver
Entity Address, Country	CA
Entity Address, State or Province	BC
Entity Address, Postal Zip Code	V6E 3T5
Entity Well Known Seasoned Issuer	No
Entity Current Reporting Status	No
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Voluntary Filers	No
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Document Accounting Standard	International Financial Reporting Standards
Title of 12(b) Security	Common Stock
Auditor Name	Reliant CPA PC
Auditor Location	Newport Beach, CA
Auditor Firm ID	6906
Business Contact [Member]
Entity Addresses [Line Items]
Contact Personnel Name	Philip Lancaster
Entity Address, Address Line One	Suite 700 - 1199 West Hastings Street
Entity Address, City or Town	Vancouver
Entity Address, Country	CA
Entity Address, State or Province	BC
Entity Address, Postal Zip Code	V6E 3T5
Local Phone Number	863-3038
City Area Code	250

Consolidated Statements of Fina

Consolidated Statements of Financial Position - CAD ($)	Nov. 30, 2023	Nov. 30, 2022
Current assets
Cash	$ 38,555	$ 13,127
Accounts receivable	0	6,870
Sales tax receivable	5,826	9,083
Inventories	0	2,175
Prepaid expenses	183,872	30,947
Total current assets	228,253	62,202
Non-current assets
Equipment	0	24,801
Right-of-use asset	0	61,198
Long-term receivable	1	0
Total assets	228,254	148,201
Current liabilities
Accounts payable	77,126	1,063,863
Lease liabilities	0	66,403
Loans payable	48,000	127,019
Deferred revenue	0	124,918
Due to related parties	372,650	705,672
Total current liabilities	497,776	2,087,875
Non-current liabilities
Lease liabilities	0	9,394
Total liabilities	497,776	2,097,269
SHAREHOLDERS' DEFICIT
Share capital	13,916,448	11,851,771
Contributed surplus	2,709,790	2,709,790
Reserves	248,928	0
Accumulated other comprehensive income	0	25,131
Accumulated Deficit	(17,144,688)	(16,535,760)
Total shareholders' deficit	(269,522)	(1,949,068)
Total liabilities and shareholders' deficit	$ 228,254	$ 148,201

Consolidated Statements of Inco

Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
OPERATING EXPENSES
General and administrative	$ 1,070,574	$ 826,439	$ 2,245,589
Business development	386,991	114,665	508,545
Total operating expenses	1,457,565	941,104	2,440,508
OTHER INCOME (EXPENSE)
Impairment loss	(209,702)	0	0
Interest income	3,765	0	0
Gain on debt forgiveness	62,500	222,771	0
Foreign exchange gain (loss)	(3,068)	(135)	(29,374)
Total other income (expense)	(146,505)	222,636	(29,374)
Loss from continuing operations	(1,604,070)	(718,468)	(2,783,508)
Gain (loss) from discontinued operations - loss of control	995,142	(1,949,330)	(2,191,326)
Net loss for the year	(608,928)	(2,667,798)	(4,974,834)
OTHER COMPREHENSIVE LOSS
Foreign currency translation gain (loss)	(25,131)	(71,262)	30,603
TOTAL COMPREHENSIVE LOSS FOR THE YEAR	$ (634,059)	$ (2,739,060)	$ (4,944,231)
Loss per share from continuing operations, Basic	$ (0.02)	$ (0.05)	$ (0.09)
Loss per share from continuing operations, Diluted	(0.02)	(0.05)	(0.09)
Earnings (Loss) per share from discontinued operations - loss of control, Basic	0.01	(0.03)	(0.04)
Earnings (Loss) per share from discontinued operations - loss of control, Diluted	$ 0.01	$ (0.03)	$ (0.04)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - continuing operations, Basic	86,795,825	59,310,826	53,075,143
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - continuing operations, Diluted	86,795,825	59,310,826	53,075,143
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - discontinued operations, Basic	86,795,825	59,310,826	53,075,143
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - discontinued operations, Diluted	126,769,515	59,310,826	53,075,143

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity (Deficit) - CAD ($)	Share capital [Member]	Contributed Surplus [Member]	Warrant reserve[Member]	Options reserve [Member]	Accumulated Deficit [Member]	Accumulated other comprehensive income [Member]	Total
Beginning Balance at Nov. 30, 2020	$ 7,376,763	$ 1,298,487	$ 0	$ 0	$ (8,893,128)	$ 65,790	$ (152,088)
Beginning Balance (Shares) at Nov. 30, 2020	42,762,264
Statements Line Items
Shares issued for warrants exercised	$ 1,332,727						1,332,727
Shares issued for warrants exercised (Shares)	6,129,572
Fair value of warrants exercised	$ 36,859	(36,859)
Shares issued for options exercised	$ 222,500
Shares issued for options exercised (Shares)	425,000
Fair value of options exercised	$ 158,106	(158,106)
Shares issued for cash	$ 2,749,000	287,499					3,036,499
Shares issued for cash (Shares)	8,930,000
Fair value of warrants issued	$ (174,427)	174,427
Shares issued to finders	$ (100,500)						(100,500)
Shares issued to finders (Shares)	336,250
Finders' Fee	$ (74,180)						(74,180)
Shares issued as compensation	$ 307,734						307,734
Shares issued as compensation (Shares)	656,250
Fair value of stock options granted		1,144,342					1,144,342
Net loss for the year					(4,974,834)		(4,974,834)
Foreign currency translation gain (loss)						30,603	30,603
Ending Balance at Nov. 30, 2021	$ 11,834,582	2,709,790	0	0	(13,867,597)	96,393	772,803
Ending Balance (Shares) at Nov. 30, 2021	59,239,336
Statements Line Items
Shares issued for options exercised							222,500
Shares issued as compensation	$ 17,189						17,189
Shares issued as compensation (Shares)	78,125
Net loss for the year					(2,667,798)		(2,667,798)
Foreign currency translation gain (loss)						(71,262)	(71,262)
Ending Balance at Nov. 30, 2022	$ 11,851,771	2,709,790	0	0	(16,535,760)	25,131	(1,949,068)
Ending Balance (Shares) at Nov. 30, 2022	59,317,461
Statements Line Items
Shares issued for cash	$ 2,278,420						2,278,420
Shares issued for cash (Shares)	43,587,000
Fair value of warrants issued	$ (149,340)		149,340
Share issuance costs	(233,403)						(233,403)
Shares issued as compensation	$ 169,000						169,000
Shares issued as compensation (Shares)	2,600,000
Fair value of stock options granted				99,588			99,588
Net loss for the year					(608,928)		(608,928)
Foreign currency translation gain (loss)						(25,131)	(25,131)
Ending Balance at Nov. 30, 2023	$ 13,916,448	$ 2,709,790	$ 149,340	$ 99,588	$ (17,144,688)	$ 0	$ (269,522)
Ending Balance (Shares) at Nov. 30, 2023	105,504,461

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
Cash Flows from Operating Activities
Net loss for the year	$ (608,928)	$ (2,667,798)	$ (4,974,834)
Adjustments to reconcile net loss to net cash used in operating activities:
Gain from loss of control of subsidiaries	(995,142)	0	0
Stock based compensation	99,588	0	1,144,342
Foreign exchange gain	(25,131)	(71,262)	0
Gain on debt forgiveness	(62,500)	(222,771)	0
Shares issued as compensation	169,000	0	0
Impairment loss	209,702	0	0
Consulting fees	0	17,189	307,734
Changes in operating assets and liabilities:
Sales tax receivable	3,257	(3,525)	(5,130)
Prepaid expenses	(152,925)	120,310	(116,136)
Due from related parties	0	0	2,500
Due to related parties	325,742	28,326	0
Accounts payable and accrued liabilities	(924,237)	(19,847)	122,411
Net cash used in operating activities - continuing operations	(1,961,574)	(2,819,378)	(3,519,113)
Net cash provided by (used in) operating activities - discontinued	(764,435)	2,405,354	78,011
Net cash used in operating activities	(2,726,009)	(414,024)	(3,441,102)
Cash Flows from Investing Activities
Long-term receivables	(209,703)	0	0
Net cash used in investing activities-continuing operations	(209,703)	0	0
Net cash provided by (used in) investing activities - discontinued	995,142	0	(573,343)
Net cash provided by (used in) investing activities	785,439	0	(573,343)
Cash Flows from Financing Activities
Shares issued for cash	2,278,420	0	4,417,046
Share issuance costs	(233,403)	0	0
Loan payable	(79,019)	105,000	0
Net cash provided by financing activities-continuing operations	1,965,998	105,000	4,417,046
Net cash used in financing activities- discontinued	0	(34,701)	(90,604)
Net cash provided by financing activities	1,965,998	70,299	4,326,442
Increase (decrease) in cash	25,428	(343,725)	311,997
Effect of foreign exchange rate changes on cash	0	(18,194)	38,336
Cash, beginning of the year	13,127	375,046	24,713
Cash, end of the year	$ 38,555	$ 13,127	$ 375,046

NATURE OF OPERATIONS AND GOING

NATURE OF OPERATIONS AND GOING CONCERN	12 Months Ended
	Nov. 30, 2023
Nature Of Operations And Ability To Continue As Going Concern Abstract
NATURE OF OPERATIONS AND GOING CONCERN [Text Block]	1. NATURE OF OPERATIONS AND GOING CONCERN Aether Global Innovations Corp. (the "Company") was incorporated under the Business Corporations Act of British Columbia on October 17, 2011. The head office, principal address and registered and records office of the Company are located at 700 - 1199 West Hastings Street, Vancouver, B.C., V6E 3T5. On August 1, 2023, the Company changed its name to Aether Global Innovation Corp. from Plymouth Rock Technologies Inc. The Company's common shares are listed on the CSE under the symbol "AETH", on the Frankfurt Stock Exchange under the Symbol: 4XA, WKN# - A2N8RH and on the OTC Markets Group ("OTCQB") under the symbol: AETHF. Previously, the Company's principal business activity through its subsidiary, Plymouth Rock USA ("PRT USA"), focused on developing technologies related to remotely detecting assault firearms and suicide bombs concealed on the person or a carry bag. The Company also incorporated a subsidiary in United Kingdom, Plymouth Rock Technologies UK Limited ("PRT UK") to augment the Company's existing research and development of its drone technologies for the US and EMEA markets. Moreover, the Company acquired Tetra Drones Limited ("Tetra") to provide the Company with drones production line in the United Kingdom. On December 1, 2022, the Company lost control over PRT USA, PRT UK, and Tetra. Hence, the Company has discontinued the above subsidiaries according to the requirements of IFRS 10 (Note 3). To date, the Company is in a transition stage to refocus the Company's business operations from developing various technologies to a drone management and solutions provider. Going Concern These consolidated financial statements are prepared on a going concern basis, which contemplates that the Company will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of business. At present, the Company's operations do not generate cash flows. The Company has incurred losses since inception and has a comprehensive loss of $634,059 for the year ended November 30, 2023, and had an accumulated deficit of $17,144,688 as at November 30, 2023. The ability of the Company to continue as a going concern is dependent on achieving profitable operations, commercializing its technologies, and obtaining the necessary financing in order to develop these technologies further. The outcome of these matters cannot be predicted at this time. The management plans to continue reviewing the prospects of raising additional debt and equity financing to support its operations until such time that its operations become self-sustaining, to fund its research and development activities and to ensure the realization of its assets and discharge of its liabilities. While the Company is expanding its best efforts to achieve the above plans, there is no assurance that any such activity will generate sufficient funds for future operations. These factors and uncertainty cast significant doubt about the Company's ability to continue as a going concern and therefore it may be unable to realize its assets and discharge its liabilities in the normal course of business. The Company is not expected to be profitable during the ensuing 12 months from the date of the issuance of the financial statement, and therefore, must rely on securing additional funds from either issuance of debt or equity financing for cash consideration. During the year ended November 30, 2023, the Company received net cash proceeds of $1,965,998 pursuant to financing activities. Management has been successful in raising capital through periodic private placements of the Company's common shares in the past, however there is no certainty that financing will be available in the future, or certainty that management's planned actions to address this situation will be successful. These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") with the assumption that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future rather than a process of forced liquidation. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence. Such adjustments could be material.

MATERIAL ACCOUNTING POLICIES

MATERIAL ACCOUNTING POLICIES	12 Months Ended
	Nov. 30, 2023
Disclosure Of Significant Accounting Policies [Abstract]
MATERIAL ACCOUNTING POLICIES [Text Block]	2. Basis of presentation These consolidated financial statements ("Financial Statements") have been prepared using accounting policies consistent with IFRS as issued by the International Accounting Standard Board ("IASB") and interpretations of the International Financial Reporting Interpretations Committee ("IFRIC"). These Financial Statements are authorized for issue by the Board of Directors on May 15, 2024. These Financial Statements have been prepared on the historical cost basis. In addition, these Financial Statements have been prepared using the accrual basis of accounting. These Financial Statements are presented in Canadian dollars, which is the Company's functional currency. The functional currency of PRT USA is U.S. Dollars and the functional currency of PRT UK and Tetra is British Pound Sterling ("£"). The assets and liabilities of PRT USA, PRT UK and Tetra are translated into Canadian dollars at the rate of exchange prevailing at the reporting date and their income and expense items are translated at average exchange rates for the period. Exchange differences arising on the translation are recognized in other comprehensive income. Critical accounting judgments, estimates and assumptions The preparation of these Financial Statements in conformity with IFRS requires management to make judgments and estimates and form assumptions that affect the reported amounts of assets and liabilities at the date of the Financial Statements and reported amounts of income and expenses during the period. Actual results could differ from these estimates. Significant estimates used in preparing the Financial Statements include, but are not limited to the following: a. The calculation of deferred tax is based on the ability of the Company to generate future taxable income, the estimation of which is subject to significant uncertainty as to the amount and timing. The calculation of deferred tax is also based on assumptions, which are subject to uncertainty as to timing and which tax rates are expected to apply when temporary differences reverse. Deferred tax recorded is also subject to uncertainty regarding the magnitude on non-capital losses available for carry forward and of the balances in various tax pools as the corporate tax returns have not been prepared as of the date of financial statement preparation. b. The fair value of stock options and finders' warrants issued are subject to the limitations of the Black-Scholes option pricing model that incorporates market data and involves uncertainty in estimates used by management in the assumptions. Because the Black-Scholes option pricing model requires the input of highly subjective assumptions, including the expected lift, volatility of share prices, risk-free rate and dividend yield, changes in subjective input assumptions can materially affect the fair value estimate. c. Impairment exists when the carrying value of an asset or cash generating unit ("CGU") exceeds its recoverable amount, which is the higher of its fair value less costs to sell and its value in use. The fair value less costs to sell calculation is based on available data from binding sales transactions in an arm's length transaction of similar assets or observable market prices less incremental costs for disposing of the asset. The value in use calculation is based on a discounted cash flow model. d. Management uses estimation in determining the incremental borrowing rate used to measure the lease liability, specific to the asset, underlying currency and geographic location. Significant judgments used in the preparation of these Financial Statements include, but are not limited to the following: (i) Management has applied judgements in the assessment of the Company's ability to continue as a going concern when preparing its Financial Statements for the year ended November 30, 2023. Management prepares the Financial Statements on a going concern basis unless management either intends to liquidate the entity or to cease trading or has no realistic alternative but to do so. In assessing whether the going concern assumption is appropriate, management accounts for all available information about the future, which is at least, but is not limited to, twelve months from the issuance of the financial statements. (ii) Determination of whether a set of assets acquired, and liabilities assumed constitute the acquisition of a business or asset may require the Company to make certain judgments as to whether or not the assets acquired, and liabilities assumed include the inputs, processes and outputs necessary to constitute a business as defined in IFRS 3 - Business Combinations. Based on an assessment of the relevant facts and circumstances, the Company concluded that the acquisition disclosed in Note 3 met the criteria for accounting as a business combination. Cash Cash consists of amounts held in banks and highly liquid investments with limited interest and credit risk. Consolidation The Financial Statements include the accounts of the Company and its wholly owned subsidiaries up to the date the Company had control (Note 3). Control exists when the Company has the power and ability, directly or indirectly, to direct the relevant activities of an entity to obtain benefit from its activities. Subsidiaries are fully consolidated from the date that control commences until the date the control ceases. The accounting policies of the Company's subsidiaries have been aligned with the policies adopted by the Company. When the Company ceases to control a subsidiary, the financial statements of the subsidiary are de-consolidated (Note 3). Equipment Recognition and measurement On initial recognition, equipment is valued at cost, being the purchase price and directly attributable cost of acquisition or construction required to bring the asset to the location and condition necessary to be capable of operating in the manner intended by the Company, including appropriate borrowing costs and the estimated present value of any future unavoidable costs of dismantling and removing the items. The corresponding liability is recognized within provisions. Equipment is subsequently measured at cost less accumulated depreciation, less any accumulated impairment losses. When parts of an item of equipment have different useful lives, they are accounted for as separate items (major components) of equipment. Gains and losses Gains and losses on disposal of an item of equipment are determined by comparing the proceeds from disposal with the carrying amount and are recognized net within other income in profit or loss. Depreciation Half of the normal depreciation is taken in the year of acquisition for equipment with declining balance method. The depreciation rates applicable to each category of property and equipment are as follows: Computer equipment 55% declining balance Vehicles 30% declining balance Furniture 20% declining balance Leasehold improvements 30% declining balance Demo equipment 20% declining balance Inventories The Company values inventories at the lower of cost and net realizable value. Cost includes the costs of purchases net of vendor allowances plus other costs, such as transportation, that are directly incurred to bring the inventories to their present location and condition. Business combinations Business combinations are accounted for using the acquisition method. The cost of the acquisition is measured at the aggregate of the fair values at the date of acquisition, of assets transferred, liabilities incurred or assumed, and equity instruments issued by the Company. The acquiree's identifiable assets and liabilities assumed are recognized at their fair value at the acquisition date. Acquisition-related costs are recognized in profit or loss as incurred. The excess of consideration over the fair value of the net identifiable assets and liabilities acquired is recorded as goodwill. Any gain on a bargain purchase is recorded in profit or loss immediately. Transaction costs are expensed as incurred, except if related to the issue of debt or equity securities. Any goodwill that arises is tested annually for impairment. Share capital The Company records proceeds from the issuance of its common shares as equity. Proceeds received on the issuance of units, consisting of common shares and warrants, are allocated between the common share and warrant component. The Company has adopted a residual value method with respect to the measurement of shares and warrants issued as private placement units. The residual value method first allocates value to the most easily measurable component based on fair value and then the residual value, if any, to the less easily measurable component. The fair value of the common shares issued in the private placement was determined to be the more easily measurable component and were valued at their fair value, as determined by the closing quoted price on the issuance date. The remaining proceeds, if any, are allocated to the attached warrants. Any fair value attributed to the warrants is recorded as warrant reserve. Management does not expect to record a value to the warrant in most equity issuances as unit private placements are commonly priced at market or at a permitted discount to market. If the warrants are issued as share issuance costs, the fair value of agent's warrants are measured using the Black-Scholes option pricing model and recognized in equity as a deduction from the proceeds. If the warrants are exercised, the related amount is reclassified as share capital. If the warrants expire unexercised, the related amount remains in warrant reserve. Incremental costs directly attributable to the issue of new common shares are shown in equity as a deduction, net of tax, from the proceeds. Common shares issued for consideration other than cash are valued based on their market value at the date that shares are issued. Stock-based payment The Company recognizes share-based payment expense for the estimated fair value of equity-based instruments granted to both employees and non-employees. Compensation expense is recognized when the options are granted with the same amount being recorded as contributed surplus. The expense is determined using an option pricing model that accounts for the exercise price, the term of the option, the current share price, the expected volatility of the underlying shares, the expected dividend yield, and the risk-free interest rate for the term of the option. If the options are exercised, the contributed surplus will be reduced by the applicable amount. Share-based payment calculations have no effect on the Company's cash position. Earnings (loss) per share Basic earnings (loss) per share are calculated using the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are calculated using the treasury stock method. This method for diluted earnings (loss) per share assumes that common shares are issued for the exercise of options, warrants and convertible securities and that the assumed proceeds from the exercise of options, warrants and convertible securities are used to purchase common shares at the average market price during the period. The difference between the number of shares assumed issued and the number of shares assumed purchased is then added to the basic weighted average number of shares outstanding to determine the fully diluted number of common shares outstanding. No calculation of diluted earnings (loss) per shares is assumed during the periods in which a net loss is incurred as the effect is anti-dilutive. Financial instruments Financial assets a) The Company classifies its financial instruments in the following categories: at fair value through profit and loss ("FVTPL"), at fair value through other comprehensive income (loss) ("FVTOCI") or at amortized cost. The Company determines the classification of financial assets at initial recognition. The classification of debt instruments is driven by the Company's business model for managing the financial assets and their contractual cash flow characteristics. Equity instruments that are held for trading are classified as FVTPL. For other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument-by-instrument basis) to designate them as at FVTOCI. Financial liabilities are measured at amortized cost, unless they are required to be measured at FVTPL (such as instruments held for trading or derivatives) or if the Company has opted to measure them at FVTPL. b) Financial assets and liabilities at amortized cost Financial assets and liabilities at amortized cost are initially recognized at fair value plus or minus transaction costs, respectively, and subsequently carried at amortized cost less any impairment. The Company's financial assets measured at amortized cost are comprised of its cash and trade and other receivables, net. The Company's financial liabilities measured at amortized cost are comprised of its accounts payable and accrued liabilities, loans payable, loans payable - related party, convertible debt, convertible debt - related parties, silent partnerships, silent partnerships - related party and lease liabilities. Financial assets and liabilities at FVTPL Financial assets and liabilities carried at FVTPL are initially recorded at fair value and transaction costs are expensed in the statements of loss and comprehensive loss. Realized and unrealized gains and losses arising from changes in the fair value of the financial assets and liabilities held at FVTPL are included in the statements of loss and comprehensive loss in the period in which they arise. Debt instruments at FVTOCI These assets are initially measured at fair value. Interest income calculated using the effective interest method, foreign exchange gains and losses and impairment are recognized in profit or loss. Other net gains and losses associated with changes in fair value are recognized in OCI. On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss. The Company does not hold any debt instruments at FVTOCI. Equity instruments at FVTOCI These assets are initially measured at fair value. Dividends are recognized as income in profit or loss unless the dividend clearly represents a recovery of part of the cost of the investment. Other net gains and losses associated with changes in fair value are recognized in OCI and are never reclassified to profit or loss. The Company does not hold any equity instruments at FVTOCI. c) The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the Company measures the loss allowance for the financial asset at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date the financial asset has not increased significantly since initial recognition, the Company measures the loss allowance for the financial asset at an amount equal to the twelve month expected credit losses. The Company shall recognize in the statements of loss and comprehensive loss, as an impairment gain or loss, the amount of expected credit losses (or reversal) that is required to adjust the loss allowance at the reporting date to the amount that is required to be recognized. d) Financial assets The Company derecognizes financial assets only when the contractual rights to cash flow from the financial assets expire, or when it transfers the financial assets and substantially all of the associated risks and rewards of ownership to another entity. Financial liabilities The Company derecognizes financial liability when its contractual obligations are discharged or cancelled or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are generally recognized in profit or loss. The Company applies the simplified approach for accounts receivable that do not contain a significant financing component. Using the simplified approach, the Company records a loss allowance equal to the expected credit losses resulting from all possible default events over the assets' contractual lifetime. Financial assets are written off when the Company has no reasonable expectations of recovering all or any portion thereof. The Company derecognizes a financial asset when its contractual rights to the cash flows from the financial asset expire. Interest Interest income and expense are recognized in profit or loss using the effective interest method. The 'effective interest rate' is the rate that exactly discounts estimated future cash payments over the expected life of the financial instrument to the gross carrying amount of the financial asset or the amortized cost of the financial liability. The effective interest rate is calculated considering all contractual terms of the financial instruments, except for the expected credit losses of financial assets. The 'amortized cost' of a financial asset or financial liability is the amount at which the instrument is measured on initial recognition minus principal repayments, plus or minus any cumulative amortization using the effective interest method of any difference between the initial amount and maturity amount and adjusted for any expected credit loss allowance. The 'gross carrying amount' of a financial asset is the amortized cost of a financial asset before adjusting for any expected credit losses. Interest income and expense is calculated by applying the effective interest rate to the gross carrying amount of the financial asset (when the asset is not credit-impaired) or the amortized cost of the financial liability. Where a financial asset has become credit-impaired subsequent to initial recognition, interest income is calculated in subsequent periods by applying the effective interest method to the amortized cost of the financial asset. If the asset subsequently ceases to be credit-impaired, calculation of interest income reverts to a gross basis. Offsetting Financial assets and financial liabilities are offset, with the net amount presented in the statement of financial position, when, and only when, the Company has a current and legally enforceable right to set off the recognized amounts and intends either to settle on a net basis or realize the asset and settle the liability simultaneously. Income and expenses are presented on a net basis only when permitted under IFRS, or when arising from a group of similar transactions if the resulting income and expenses are not material. Revenue recognition Revenue is recognized by applying the five-step model under IFRS 15. The Company recognizes revenue when, or as the goods or services are transferred to the control of the customer and performance obligations are satisfied. The Company's revenue is comprised of sales of its radar systems, radar components and engineering design and development services. The Company's revenue is recognized when control of the goods has been transferred, when the goods are delivered to customers and when all performance obligations have been fulfilled. The amounts recognized as revenue represent the fair values of the considerations received or receivable from third parties on the sales of goods to customers, net of goods and services taxes and less returns, and discounts, at which time there are no conditions for the payment to become due other than the passage of time. For its engineering design and development services, revenue is recognized when the service has been rendered. Deferred revenue The Company recognizes deferred revenue when the customers pay in advance for the goods or services to be delivered in future periods. Revenue will be recognized in the future period when the goods and services are provided and in accordance with IFRS 15. Government grants Government grants are recognized at fair value once there is reasonable assurance that the Company will comply with the conditions attached to the grants and that the grants will be received. Government grants are recognized in profit or loss on a systematic basis over the periods in which the Company recognizes as expenses the related costs for which the grants are intended to compensate. A forgivable loan from the government is treated as a government grant when there is reasonable assurance that the entity will meet the terms for forgiveness of the loan. Income taxes Income tax is recognized in profit or loss except to the extent that it relates to equity items, in which case it is recognized in equity. Current tax expense is the expected tax payable on the taxable income for the year, using tax rates enacted at period end, adjusted for amendments to tax payable with regards to previous years. Deferred tax is recorded using the liability method, providing for temporary differences, between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. The following temporary differences do not result in deferred tax assets or liabilities: goodwill not deductible for tax purposes; the initial recognition of assets or liabilities that affect neither accounting profit (loss) nor taxable profit (loss); and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the financial position date. A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized. Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when they relate to income taxes levied by the same taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis. Related party transactions Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control and related parties may be individuals or corporate entities. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. Leases The Company adopted IFRS 16 effective December 1, 2019. The Company chose to adopt the modified retrospective approach on transition to IFRS 16 and has chosen not to restate comparative information in accordance with the transitional provisions in IFRS 16. As a result, the comparative information continues to be presented in accordance with the Company's previous accounting policies. The adoption of IFRS 16 resulted in the recognition of a right-of-use asset and a lease liability measured at the present value of the future lease payments on the consolidated statements of financial position. An amortization expense on the right-of-use asset and an interest expense on the lease liability has replaced the operating lease expense. IFRS 16 has changed the presentation of cash flows relating to leases in the Company's consolidated statements of cash flows, however, it does not cause a difference in the amount of cash transferred between the parties of the lease. Subsidiaries Subsidiaries are entities controlled by the Company. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. The financial statements of subsidiaries are included in the consolidated financial statements from the date on which control commences until the date on which control ceases. Where necessary, adjustments are made to the financial statements of subsidiaries to bring their accounting policies in line with those adopted by the Company. Changes in the Company's interest in a subsidiary that do not result in a loss of control are accounted for as equity transactions. Loss of control When the Company loses control over a subsidiary, it derecognizes the assets and liabilities of the subsidiary, and any related NCI and other components of equity. Any resulting gain or loss is recognized in the consolidated statement of operations. Any interest retained in the former subsidiary is measured at fair value when control is lost. Discontinued operations The Company classifies a component of the reporting entity is disposed of as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on a reporting entity's operations and financial results. Such disposal groups are measured at the lower of their carrying amount and fair value less costs to sell. A disposal Company qualifies as discontinued operations if it is a component of an entity that either has been disposed of, or is classified as held for sale, and: • Represents a separate major line of business or geographical area of operations. • Is part of a single coordinated plan to dispose of a separate major line of business or geographical area of operations. • Is a subsidiary acquired exclusively with a view to re‐sell Loss from discontinued operations is excluded from net loss from continuing operations and are presented as a single amount under "loss from discontinued operations" account in the consolidated statement of loss and comprehensive loss. Accounting standards, amendments and interpretations not yet effective Certain new standards, interpretations and amendments to existing standards have been issued by the IASB or the IFRIC during the period but are not yet effective. Some updates that are not applicable or are not consequential to the Company may have been excluded from the list below. IAS 1 - Classification of Liabilities as Current or Noncurrent existence at the end of the reporting period, specify that classification is unaffected by expectations about whether an entity will exercise its right to defer settlement of a liability, explain that rights are in existence if covenants are complied with at the end of the reporting period, and introduce a definition of 'settlement' to make clear that settlement refers to the transfer to the counterparty of cash, equity instruments, other assets or services. The amendments are effective for annual reporting periods beginning on or after January 1, 2023. Earlier adoption is permitted. IAS 16 - Proceeds before Intended Use These new and amended standards are not expected to have a material impact on the Company's Financial Statements

DISCONTINUED OPERATIONS - LOSS

DISCONTINUED OPERATIONS - LOSS OF CONTROL	12 Months Ended
	Nov. 30, 2023
Discontinued Operations [Abstract]
DISCONTINUED OPERATIONS - LOSS OF CONTROL [Text Block]	3. DISCONTINUED OPERATIONS - LOSS OF CONTROL During first two quarters of fiscal year ending November 30, 2023, the Company did a full review on UK Operations (PRT UK and Tetra Drones) to mitigate further losses on these subsidiaries. After months of discussion, the Board decided that to protect the interest of shareholders, the Company will be better off putting the UK subsidiaries under liquidation. Therefor on June 16, 2023, the Company announced its decision to close down previously controlled subsidiaries, PRT UK and Tetra Drones as a result of the move towards a drone management and monitoring solutions business. On July 6, 2023, pursuant to a special resolution by its Directors, PRT UK was wound up voluntarily and appointed liquidators in the UK for the purposes of such winding up. On September 4, 2023, pursuant to a special resolution by its Directors, Tetra Drones was also put into liquidation. Similarly, due to difficulty in obtaining complete and accurate books and records, resignation of key management personnel in the US Subsidiary, on July 20, 2023, the Company announced that it has also ceased operations with its U.S. Subsidiary, PRT USA. During the third quarter of fiscal year ending November 30, 2023, the Company determined that based on their decision to put PRT UK and Tetra Drones into liquidation and to cease operations with PRT USA, the Company no longer has control over the operations of the said subsidiaries and there is no intent from management to continue operating these businesses. The Company assessed the date of loss of control and determined it be December 1, 2022 as no reliable financial records and supporting documents were accessible from the three subsidiaries for financial reporting purposes subsequent to November 30, 2022. Discontinued Operations As a result of loss of control, the Company considered its PRT UK, PRT USA and Tetra Drones operations to have met the definition of discontinued operations and as such, assets, liabilities and results of operations that can be distinguished operationally and for financial reporting purposes from the rest of the Company have been terminated and reported separately in the financial statements. A discontinued operation is a component of the Company that either has been abandoned, disposed of, or is classified as held for sale, and: (i) represents a separate major line of business or geographical area of operation; (ii) is part of a single coordinated plan to dispose of a separate major line of business or geographical area of operation; or (iii) is a subsidiary acquired exclusively with a view to resell. During the year ended November 30, 2023, the gain (loss) from discontinued operations - loss of control presented in the statement of loss and comprehensive loss is broken down as follows: Year ended November 30 2023 2022 2021 Net Gain (Loss) from discontinued operations - loss of control $ 995,142 $ (1,949,330 ) $ (2,191,326 ) The results of operations of PRT USA, PRT UK and Tetra Drones for the years ended November 30, 2023, 2022 and 2021 were presented separately as loss from discontinued operations of subsidiaries - loss of control in the consolidated statements of loss and comprehensive loss. The amounts are broken down as follows: For the years ended November 30 2023 2022 2021 Sales $ - $ 607,359 $ 184,396 Cost of sales - (191,175 ) (103,109 ) Gross Profit - 416,184 81,287 OPERATING EXPENSES General and administrative - 1,519,539 1,074,492 Business development - 62,763 200,465 Research and development - 233,264 985,006 Total expenses - 1,815,566 2,259,963 OTHER INCOME (EXPENSES) Impairment loss on Demo Equipment - (236,677 ) - Impairment of intangible asset - (330,650 ) - Other Income - 5,042 - Gain on debt forgiveness - 11,532 - Foreign exchange gain (loss) - 805 (12,650 ) Total other income (expense) - (549,948 ) (12,650 ) Loss from discontinued operations $ - $ (1,949,330 ) $ (2,191,326 ) After the loss of control, the Company also deconsolidated the net liabilities of the previously controlled subsidiaries for financial reporting purposes. The Company did not receive anything from the disposal of its investments. This then resulted in a gain from loss of control of subsidiaries for the year ended November 30, 2023. Gain from loss of control of subsidiaries The resulting gain from the loss of control of subsidiaries for the year ended November 30, 2023, is broken down as follows: PRT USA PRT UK Tetra Drones Total Net liabilities before loss of control of subsidiaries $ 4,870,623 $ 1,481,194 $ 227,907 $ 6,579,724 Foreign currency translation adjustments (123,484 ) 25,310 3,023 (95,151 ) Less: Receivables from subsidiaries (4,248,018 ) (1,120,913 ) (120,500 ) (5,489,431 ) Gain from loss of control of subsidiaries $ 499,121 $ 385,591 $ 110,430 $ 995,142 (a) During the year ended November 30, 2023, following the loss of control over PRT USA, the Company derecognized its investment in this subsidiary. The Company has not received any consideration on the disposal of its investment. As such, the total carrying value of the net liabilities of PRT USA of $4,870,623 was recognized as a gain on loss of control of the subsidiaries in the consolidated statements of loss and comprehensive loss for the year ended November 30, 2023. Additionally (or Further), as at November 30, 2023, the parent company had a receivable from PRT USA amounting to $4,248,018. Due to uncertainty surrounding collectability, the Company impaired this intercompany receivable and reported it as part of gain from loss of control in the consolidated statements of loss and comprehensive loss for the year ended November 30, 2023. After accounting for foreign exchange translation losses, the gain from loss of control recognized in the consolidated statements of loss and comprehensive loss amounted to $499,121 (2022 - $Nil). As at December 1, 2022 ASSETS Current Assets Cash, cash equivalents, and restricted cash $ 9,700 Prepaid expenses 8,313 Account receivable 6,831 Inventories 2,163 Total current assets of discontinued operations 27,007 Non-current assets Equipment 5,919 Right of use asset 38,189 Total non-current assets of discontinued operations 44,108 Assets of discontinued operations $ 71,115 LIABILITIES Liabilities Accounts payable $ 284,181 Lease liability 671,205 Due to related parties 4,608,071 Liabilities of discontinued operation 4,941,738 Carrying value of net liabilities immediately prior to loss of control of subsidiary $ 4,870,623 Receivable from PRT USA (4,248,018 ) Reclassification of foreign currency translation (123,484 ) Gain from loss of control of PRT USA $ 499,121 (b) During the year ended November 30, 2023, following the loss of control over PRT UK, the Company derecognized its investment in this subsidiary. The Company has not received any consideration on the disposal. As such, the total value of the net liabilities of PRT UK was recognized as a gain on loss of control of the subsidiaries in the consolidated statements of loss and comprehensive loss. As such, the total carrying value of the net liabilities of PRT UK of $1,481,194 was recognized as a gain on loss of control of the subsidiaries in the consolidated statements of loss and comprehensive loss for the year ended November 30, 2023. Additionally, as at November 30, 2023, the parent company had a receivable from PRT UK amounting to $1,120,913. Due to uncertainty surrounding collectability, the Company impaired this intercompany receivable and reported it as part of gain from loss of control in the consolidated statements of loss and comprehensive loss for the year ended November 30, 2023. After accounting for foreign exchange translation gains, the gain from loss of control recognized in the consolidated statements of loss and comprehensive loss amounted to $385,591 (2022 - $Nil). As at December 1, 2022 ASSETS Current Assets Cash, cash equivalents, and restricted cash $ 3,852 Prepaid expenses 8,983 Total current assets of discontinued operations 12,835 Non-current assets Equipment 9,171 Right of use asset 24,686 Total non-current assets of discontinued operations 33,857 Assets of discontinued operations $ 46,692 LIABILITIES Current Liabilities Accounts payable $ 455,062 Current Lease Liability 26,456 Due to related parties 919,436 Deferred revenue 124,918 Liabilities of discontinued operations $ 1,527,886 Carrying value of net liabilities immediately prior to loss of control of subsidiary $ 1,481,194 Receivable from PRT UK (1,120,913 ) Foreign exchange gains 25,310 Gain from loss of control of PRT UK $ 385,591 (c) On December 1, 2022, following the loss of control over Tetra Drones, the Company derecognized its investment in this subsidiary. The Company has not received any consideration on the disposal. As such, the total value of the net liabilities of Tetra Drones was recognized as a gain on loss of control of the subsidiaries in the consolidated statements of income (loss) and comprehensive income (loss). As such, the total carrying value of the net liabilities of PRT UK of $227,907 was recognized as a gain on loss of control of the subsidiaries in the consolidated statements of loss and comprehensive loss for the year ended November 30, 2023. Additionally, as at November 30, 2023, the parent company had a receivable from Tetra Drones amounting to $120,500. Due to uncertainty surrounding collectability, the Company impaired this intercompany receivable and reported it as part of gain from loss of control in the consolidated statements of loss and comprehensive loss for the year ended November 30, 2023. After accounting for foreign exchange translation gains, the gain from loss of control recognized in the consolidated statements of loss and comprehensive loss amounted to $110,430 (2022 - $Nil). As at December 1, 2022 ASSETS Current Assets Sales tax receivable $ 435 Total current assets of discontinued operations 435 Non-current assets Equipment 9,982 Total non-current assets of discontinued operations 9,982 Assets of discontinued operations $ 10,417 LIABILITIES Current Liabilities Bank Overdraft $ 16,294 Accounts payable 12,043 Due to related parties 209,738 Loan payable - current 249 Liabilities of discontinued operations $ 238,324 Carrying value of net liabilities immediately prior to loss of control of subsidiary $ 227,907 Receivable from Tetra Drones (120,500 ) Foreign exchange gains 3,023 Gain from loss of control of Tetra Drones $ 110,430

PREPAID EXPENSES

PREPAID EXPENSES	12 Months Ended
	Nov. 30, 2023
Disclosure Of Detail Information About Prepaid Expenses [Abstract]
PREPAID EXPENSES [Text Block]	4. As at November 30, 2023, and November 30, 2022, the Company's prepaid expenses consist of the following: November 30, 2023 November 30, 2022 Advertising and promotions $ - $ 113 Investor relations 85,510 - Professional fees 7,469 - Consulting fees 80,000 - Rent - 8,247 Transfer agent and filing fees 7,143 13,748 Insurance 3,750 8,839 $ 183,872 $ 30,947 The prepayments for advertising and business development include prepayments for marketing and awareness programs handled by an arms' length parties for a six to twelve-month period. Consulting fees consist of prepayment for advisory services to develop new business relationships and general business consulting services to the company. Investor relations fees consist of prepayment for consultants for strategic investor discussions and market awareness of the Company. Prepaid rent pertains to the amount paid for the security deposit of the rent while prepayments for transfer agent and filing fees include annual fee of transfer agent for the issuance of shares, closing of private placement and other related compliance.

EQUIPMENT

EQUIPMENT	12 Months Ended
	Nov. 30, 2023
Property, plant and equipment [abstract]
EQUIPMENT [Text Block]	5. Equipment refers to various computer, furniture, vehicles, leasehold improvements and demo equipment used by the previously-controlled subsidiaries (Note 3), in the ordinary course of business. As at November 30, 2023, the Company derecognized property, plant and equipment with a net book value of $24,801 in connection with loss of control of its subsidiaries (Note 3). Computer Furniture Vehicles Leasehold Improvement Demo Equipment Total $ $ $ $ $ $ Cost: Balance at November 30, 2021 24,028 19,271 16,014 3,826 239,747 302,886 Disposal - - (16,243 ) - - (16,243 ) Foreign currency translation adjustment (997 ) 190 229 (182 ) 3,158 2,398 Balance at November 30, 2022 23,031 19,461 - 3,644 242,905 289,041 Foreign currency translation adjustment 361 206 - 59 2,653 3,279 Disposals due to discontinued operations (23,392 ) (19,667 ) - (3,703 ) (245,558 ) (292,320 ) Balance at November 30, 2023 - - - - - - Accumulated Depreciation: Balance at November 30, 2021 1,716 5,473 1,218 291 - 8,698 Amortization 9,236 2,688 4,210 1,006 - 17,140 Disposal - - (5,375 ) - - (5,375 ) Impairment - - - - 236,677 236,677 Foreign currency translation adjustment 642 296 (53 ) (13 ) 6,228 7,100 Balance at November 30, 2022 11,594 8,457 - 1,284 242,905 264,240 Amortization 1,593 554 - 179 - 2,326 Foreign currency translation adjustment 180 81 - 23 2,653 2,937 Disposals due to discontinued operations (13,367 ) (9,092 ) - (1,486 ) (245,558 ) (269,503 ) Balance at November 30, 2023 - - - - - - Net Book Value: At November 30, 2022 11,437 11,004 - 2,360 - 24,801 At November 30, 2023 - - - - - -

LONG-TERM RECEIVABLE

LONG-TERM RECEIVABLE	12 Months Ended
	Nov. 30, 2023
Disclosure Of Long Term Receivable [Abstract]
LONG-TERM RECEIVABLE [Text Block]	6. During the year ended November 30, 2023, the Company provided facility agreements with a third party to fund the latter's new and existing business opportunities. This solidifies the Company's commitment to further its partnership with the third party and the move towards autonomous drone applications through further development of a dedicated drone docking station. On May 29, 2023, the Company signed a facility agreement with a third party wherein the Company will provide a total of £50,000 ($84,929). The agreement provides for a 5% annual interest rate and the Company has the option to convert the full amount to 5% of the diluted share capital of the third party. On July 25, 2023, the Company signed another facility agreement with a third party wherein the Company will provide a total of £35,000 for general corporate purposes and it has sent a total of £35,000 ($60,151). The agreement provides for a 5% annual interest rate and the Company has the option to convert the full amount to 3.5% of the diluted share capital of the third party. On August 11, 2023, the Company signed another facility agreement with a third party wherein the Company will provide £15,000 for general corporate purposes and it has sent a total of £15,000 ($26,017). The agreement provides for a 5% annual interest rate and the Company has the option to convert the full amount to 1.5% of the diluted share capital of the third party. On September 28, 2023, the Company signed another facility agreement with a third party wherein the Company will provide £10,000 for general corporate purposes and it has sent a total of £10,000 ($17,093). The agreement provides for a 5% annual interest rate and the Company has the option to convert the full amount to 1% of the diluted share capital of the third party. On November 24, 2023, the Company signed another facility agreement with a third party wherein the Company will provide £10,000 for general corporate purposes and it has sent a total of £10,000 ($17,749). The agreement provides for a 5% annual interest rate and the Company has the option to convert the full amount to 1% of the diluted share capital of the third party. As at November 30, 2023, the Company has loaned to the third party a total of £122,203 ($209,702) including the interest incurred of £2,203 ($3,765). No conversion was made as at year ended November 30, 2023. However, due to uncertainty surrounding collectability, the Company recognized impairment loss in the consolidated statements of loss and comprehensive loss amounting to $209,702 (Note 20).

ACCOUNTS PAYABLE

ACCOUNTS PAYABLE	12 Months Ended
	Nov. 30, 2023
Disclosure Of Detail Information About Accounts Payable [Abstract]
ACCOUNTS PAYABLE [Text Block]	7. As at November 30, 2023, and 2022, the Company's accounts payable consist of the following: November 30, 2023 November 30, 2022 Professional fees $ 22,116 $ 382,805 Funds to be returned to investors 43,046 43,046 Advertising costs 2,520 34,705 Payroll - 268,610 Development costs - 168,925 Bank overdraft - 16,036 VAT Payable - 61,262 Purchases - 2,121 Rent - 1,822 Others 9,444 84,531 $ 77,126 $ 1,063,863

DEFERRED REVENUE

DEFERRED REVENUE	12 Months Ended
	Nov. 30, 2023
Disclosure of disaggregation of revenue from contracts with customers [abstract]
DEFERRED REVENUE [Text Block]	8. As of November 30, 2022, the former subsidiary, PRT UK had an advance payment from their customers as consideration for the Company's product and services to be rendered in the future date amounting to $124,918. The company had classified the above customer advance as Deferred Revenue for the year ended November 30, 2022. On December 1, 2022, the company had lost control over PRT UK and accordingly recognized the balance of $124,918 as part of the gain on disposal of subsidiaries in the consolidated statements of income (loss) and comprehensive income (loss) (Note 3).

RELATED PARTY TRANSACTIONS AND

RELATED PARTY TRANSACTIONS AND BALANCES	12 Months Ended
	Nov. 30, 2023
Related party transactions [abstract]
RELATED PARTY TRANSACTIONS AND BALANCES [Text Block]	9. Key management compensation The amounts due to and from related parties are due to the directors and officers of the Company. The balances are unsecured, non-interest bearing and due on demand. These transactions are in the normal course of operations and have been valued in these consolidated financial statements at the exchange amount, which is the amount of consideration established and agreed to by the related parties. Key management is comprised of directors and officers of the Company. As at November 30, 2023, $372,650 (November 30, 2022- $705,672) are due to directors and officers of the Company: November 30, 2023 November 30, 2022 Company controlled by the President and CEO $ 6,077 $ 78,750 Director and Chairman - 1,731 Former CFO of the Company - 67,540 Former interim CEO of the Company - 250,179 Former CEO and Director 361,573 307,472 Company controlled by a director 5,000 - $ 372,650 $ 705,672 During the years ended November 30, 2023, and 2022 and 2021, the Company entered into the following transactions with related parties: November 30, 2023 November 30, 2022 November 30, 2021 Management fees $ 92,127 $ - $ 55,000 Consulting fees 47,500 135,000 307,734 Accounting fees 63,844 - 36,202 Professional fees 10,429 - - Stock-based compensation 57,425 - 410,132 Salaries and benefits 54,100 330,337 313,626 Others 7,144 - 5,000 $ 332,569 $ 465,337 $ 1,127,694 Management fees consisted of the following: November 30, 2023 November 30, 2022 November 30, 2021 Company controlled by the President and CEO $ 35,000 $ - $ - CFO 30,000 - Former Interim CEO 27,127 - - Former CFO of the Company - - 55,000 $ 92,127 $ - $ 55,000 Consulting fees consisted of the following: November 30, 2023 November 30, 2022 November 30, 2021 Company controlled by the President and CEO $ 47,500 $ 75,000 $ - Company controlled by the Former Corporate Secretary - 60,000 - Director - - 307,734 $ 47,500 $ 135,000 $ 307,734 Accounting fees of $63,844 (2022 - $Nil and 2021 - $36,202) were paid or accrued to a company controlled by a director. During the year ended November 30, 2023, the Company entered into a loan agreement with the CEO for $6,000 and an interest of 10%. The loan was repaid within the year and all accrued interest was forgiven (Note 10). Professional fees consisted of the following: November 30, 2023 November 30, 2022 November 30, 2021 CFO and Former Corporate Secretary $ 1,000 $ - $ - Company controlled by the Corporate Secretary 9,429 - - $ 10,429 $ - $ - During the year ended November 30, 2023, the Company had 1,850,000 (November 30, 2022 - 1,750,000) stock options held by the Directors and officers of the Company. The amount recognized as expense for these options for the year ended November 30, 2023, 2022, and 2021 are as follows: November 30, 2023 November 30, 2022 November 30, 2021 Number of Options Expense for the Number of Expense Number of Expense CEO 800,000 $ 24,834 - $ - - $ - CFO 200,000 6,208 - - - - Corporate Secretary 50,000 1,552 - - - - Former CEO - - 600,000 - 600,000 $ 133,275 Former CFO - - 150,000 - 150,000 33,319 Former Corporate Secretary - - 150,000 - 150,000 33,319 Directors 800,000 24,868 750,000 - 825,000 210,219 1,850,000 $ 57,462 1,650,000* $ - 1,725,000 $ 410,132 *During the year ended November 30, 2023, 1,650,000 stock options held by the former Directors and former Officers were cancelled due to resignation from their position Salaries of $54,100 (2022- $330,337 and 2021 - $313,626) were paid or accrued to the Former CEO. Others consisted of: (1) Travel of $3,467 (2022 - $Nil and 2021 - $Nil) paid or accrued to a company controlled by a CEO; (2) Office and general expenses $3,677 (2022 - $Nil and 2021 - $Nil) paid or accrued to a company controlled by the CEO; and (3) Rent of $Nil (2022 - $Nil and 2021 - $5,000) were paid or accrued to a company controlled by a director. Gain on debt forgiveness of $62,500 (2022 - $Nil and 2021 - $Nil) is the consulting fees forgiven by the company controlled by the President and CEO. The amount is recognized in the statement of loss and comprehensive loss as the consulting fees were approved by the Board in the ordinary course of business and the CEO is not a primary shareholder of the Company.

LOANS PAYABLE

LOANS PAYABLE	12 Months Ended
	Nov. 30, 2023
Disclosure of detailed information about borrowings [abstract]
LOANS PAYABLE [Text Block]	10. LOANS PAYABLE Upon acquisition of Tetra Drones (Note 3), the Company assumed the latter's outstanding loan of £13,253 ($21,461) as of November 30, 2022. The collateral of this loan is a vehicle. On October 25, 2022, the loan and the vehicle were released to former shareholder of Tetra Drones in exchange for forgoing the remaining acquisition cost of £140,000 ($222,771). Thus, for the year ended November 30, 2022, the Company's liabilities in the vehicle and the remaining balance in the acquisition cost were extinguished. For the year ended November 30, 2022, the current loan payable of $127,019 consisted of $75,000 plus interest of $4,019 payable to a third party, which is equal to 12% interest per annum payable on demand. This includes as well the $30,000 plus 60% fixed interest on Principal amount totaling $18,000 due to default as per agreement. During the year ended November 30, 2023, the Company made a full repayment of the loan to a third party entered in August 2022 amounted to $81,238 that consists of $75,000 plus interest of $6,238 equal to 12% interest per annum. During the year ended November 30, 2023, the Company entered into loan agreements with third parties amounting to $4,000 and from the CEO amounting to $6,000 (Note 9) with interest of 10% per annum. The loans were repaid within the year and interest accrued were forgiven on these loans. As at November 30, 2023, the Company has outstanding loan payable of $48,000 (2022 - $127,019) which consist of a loan with a principal amount of $30,000 plus 60% fixed interest on Principal amount totaling $18,000 due to default as per agreement.

CAPITAL MANAGEMENT

CAPITAL MANAGEMENT	12 Months Ended
	Nov. 30, 2023
Capital Management [Abstract]
CAPITAL MANAGEMENT [Text Block]	11. CAPITAL MANAGEMENT The Company considers its capital structure to include net residual equity of all assets, less liabilities. The Company's objectives when managing capital are to (i) maintain financial flexibility in order to preserve its ability to meet financial obligations and continue as a going concern; (ii) maintain a capital structure that allows the Company to pursue the development of its projects and products; and (iii) optimize the use of its capital to provide an appropriate investment return to its shareholders commensurate with risk. The Company's financial strategy is formulated and adapted according to market conditions in order to maintain a flexible capital structure that is consistent with its objectives and the risk characteristics of its underlying assets. The Company manages its capital structure and adjusts it in light of changes in economic conditions and the risk characteristics of its underlying assets. To maintain or adjust the capital structure, the Company may attempt to issue new shares or acquire or dispose of assets.

SHARE CAPITAL

SHARE CAPITAL	12 Months Ended
	Nov. 30, 2023
Disclosure of classes of share capital [abstract]
SHARE CAPITAL [Text Block]	12. (a) Common Shares Authorized: Unlimited number of common shares without par value As at November 30, 2023, there were 105,504,461 common shares issued and outstanding (November 30, 2022 - 59,317,461). During the year ended November 30, 2023: On July 24, 2023, the Company closed a non-brokered private placement and issued 9,907,000 common shares at a price of $0.06 per unit for gross proceeds of $594,420. Each Unit is comprised of one (1) common share and one (1) common share purchase warrant, with each whole warrant entitling the holder to purchase one additional common share at a price of $0.10 for five Each finder's b-warrant entitles the holder to purchase one additional common share at a price of $0.10 for five On May 30, 2023, the Company issued 2,600,000 common shares as compensation for Investor relations to an arm's length party valued at a total of $169,000. On March 30, 2023, the Company closed a non-brokered private placement and issued 26,480,000 common shares at a price of $0.05 per unit for gross proceeds of $1,324,000. Each Unit is comprised of one (1) common share and one (1) common share purchase warrant, with each whole warrant entitling the holder to purchase one additional common share at a price of $0.10 for three three On March 27, 2023, the Company closed a non-brokered private placement and issued 7,200,000 common shares at a price of $0.05 per unit for gross proceeds of $360,000. Each Unit is comprised of one (1) common share and one (1) common share purchase warrant, with each whole warrant entitling the holder to purchase one additional common share at a price of $0.10 for three three During the year ended November 30, 2022: On December 31, 2021, the Company issued 78,125 common shares as compensation for consulting fees to a director valued at a total of $17,189. During the year ended November 30, 2021: On August 9, 2021, the Company issued 5,750,000 Units at $0.40 per unit for proceeds of $2,300,000. Each unit comprised one common share and one full non-transferable common share purchase warrant, with each warrant entitling the holder to purchase one additional common share at a price of $0.50 for five years. The Company paid cash of $63,700, issued 166,250 finders' Units with a fair value of $66,500 and 325,750 broker warrants as finder's fees. Each finders' Unit comprised of one common share and one full non-transferable common share purchase warrant, with an exercise price of $0.50 per share for five years. The broker warrants are exercisable at $0.50 per share for five years. On January 29, 2021, the Company issued 3,180,000 Units at $0.20 per unit for proceeds of $636,000. Each unit comprised one common share and one full non-transferable common share purchase warrant, with each warrant entitling the holder to purchase one additional common share at a price of $0.25 for five years. The Company paid cash of $10,480, issued 170,000 finders' Units with a fair value of $34,000 and 222,400 broker warrants as finder's fees. Each finder's Unit is comprised of one common share and one full non-transferable common share purchase warrant with exercise price of $0.25 per share for five years. The broker warrants are exercisable at $0.25 per share for five years. During the year ended November 30, 2021, the Company issued 425,000 common shares for gross proceeds of $222,500 from the exercise of 425,000 stock options at $0.50 to $0.60 per share. During the year ended November 30, 2021, the Company issued 6,129,573 common shares for gross proceeds of $1,332,727 from the exercise of 6,129,573 share purchase warrants at $0.20 to $0.50 per share. During the year ended November 30, 2021, the Company issued 656,250 common shares with total fair value of $307,734 were issued as compensation for consulting fees to a director (Note 9). (b) The Company maintains an incentive stock option plan (the "Option Plan") which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees, and consultants to the Company, non-transferable options to purchase common shares, provided that the number of common shares reserved for issuance will not exceed 10% of the issued and outstanding common shares in the capital of the Company at the time of granting of options. During the year ended November 30, 2023: On October 19, 2023, the Company granted 1,000,000 incentive stock options vesting immediately to a consultant with an exercise price of $0.05 per share for a period of three years from the date of grant. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.02351, volatility 91%, risk-free rate 4.91%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $23,540. On August 18, 2023, the Company granted 2,450,000 incentive stock options to Directors, Officers and consultants with an exercise price of $0.05 per share for a period of three years from the date of grant. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.03104, volatility 96%, risk-free rate 4.51%, dividend yield 0%, and expected life of 3 years. With these assumptions, the fair value of options was determined to be $76,048. 1,800,000 stock options issued to Directors and Officers vest immediately and 650,000 stock options issued to consultants vests in 4 months. During the year ended November 30, 2023, 2,200,000 options, 1,550,000 options and 150,000 options with exercise prices of $0.60, 0.75 and 0.50, respectively, were cancelled. During the year ended November 30, 2022: 125,000 stock options with an exercise price of $0.50 were cancelled. 75,000 stock options with an exercise price of $0.50 expired unexercised. During the year ended November 30, 2021: On June 10, 2021, the Company granted 150,000 incentive stock options to a consultant with an exercise price of $0.50 per share for a period of five years from the date of grant. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.485, volatility 100%, risk-free rate 0.82%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $53,677, and the amount was recognized on the consolidated statements of loss and comprehensive loss for the year ended November 30, 2021. On January 21, 2021, the Company granted 1,550,000 incentive stock options to directors, consultants, and employees with an exercise price of $0.75 per share for a period of five years from the date of grant. The fair value was estimated using the Black-Scholes pricing model with estimated stock price of $0.75, volatility 100%, risk-free rate 0.43%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $1,022,995, and the amount was recognized on the consolidated statements of loss and comprehensive loss for the year ended November 30, 2021. Stock-based compensation recognized in profit or loss for the year ended November 30, 2023, amounted to $37,405 (2022 - $Nil; and 2021 - $1,144,342). Stock option transactions and the number of stock options outstanding as at November 30, 2023, November 30, 2022, and November 30, 2021, are summarized as follows: Number of Weighted Average Options Exercise Price Balance, November 30, 2021 4,225,000 $ 0.64 Expired (75,000 ) 0.50 Cancelled (125,000 ) 0.50 Balance, November 30, 2022 4,025,000 $ 0.66 Cancelled (3,900,000 ) 0.66 Granted 3,450,000 0.04 Balance, November 30, 2023 3,575,000 $ 0.06 The following summarizes the stock options outstanding at November 30, 2023: Expiry Date Exercise Price Numbers of options outstanding Numbers of options exercisable Weighted average remaining contractual life (year) Weighted average exercise price $ $ November 28, 2024 0.50 125,000 125,000 0.03 0.02 August 18, 2026 0.05 2,450,000 2,357,917 1.86 0.03 October 19, 2028 0.05 1,000,000 1,000,000 1.37 0.01 3,575,000 3,482,917 3.26 0.06 c) During the year ended November 30, 2023: On July 24, 2023, pursuant to the closing of the private placement, the Company issued 9,907,000 common share purchase warrants. Each warrant entitles its holder to acquire one common share of the Company at a price of $0.10 per share for a period of 5 years following the date of the issuance. The Company has allocated 100% proceeds to common share and $Nil to share purchase warrants by adopting the residual approach. On July 24, 2023, pursuant to the finder's agreement in relation to the Offering, the Company issued 990,700 share warrants to the agent with an exercise price of $0.10 for a period of 5 years from the date of issuance. The share warrants were valued at $45,364 using Black-Scholes Option Pricing model with the following assumptions: average risk-free rate - 3.9%; expected life - 5 years; expected volatility - 100%; forfeiture rate - Nil and expected dividends - $Nil. On March 30, 2023, pursuant to the closing of the private placement, the Company issued 26,480,000 common share purchase warrants as part of the private placement. Each warrant is exercisable to purchase one common share at an exercise price of $0.10 for three (3) years from the closing of the Offering. The Company has allocated 100% proceeds to common share and $Nil to share purchase warrants by adopting the residual approach. On March 30, 2023, pursuant to the agency agreement in relation to the Offering, the Company issued 2,648,000 share warrants to the agent with an exercise price of $0.10 for a period of 3 years from the date of issuance. The share warrants were valued at $94,537 using Black-Scholes Option Pricing model with the following assumptions: average risk-free rate - 3.53%; expected life - 3 years; expected volatility - 100%; forfeiture rate - Nil and expected dividends - $Nil. On March 27, 2023, pursuant to the closing of the private placement, the Company issued 7,200,000 common share purchase warrants as part of the private placement. Each warrant is exercisable to purchase one common share at an exercise price of $0.10 for for three (3) years from closing of the Offering. The Company has allocated 100% proceeds to common share and $Nil to share purchase warrants by adopting the residual approach. On March 27, 2023, pursuant to the agency agreement in relation to the Offering, the Company issued 200,000 share warrants to the agent with an exercise price of $0.10 for a period of 3 years from the date of issuance. The share warrants were valued at $9,439 using Black-Scholes Option Pricing model with the following assumptions: average risk-free rate - 3.4%; expected life - 3 years; expected volatility - 100%; forfeiture rate - Nil and expected dividends - $Nil. During the year ended November 30, 2022 561,081 warrants with exercise price of $0.20 expired unexercised. During the year ended November 30, 2021 On August 9, 2021, the Company issued 5,916,250 common share purchase warrants as part of the private placement. Each warrant is exercisable to purchase one common share at an exercise price of $0.50 per share until August 9, 2026. On August 9, 2021, the Company also granted 325,750 warrants to finder's warrants as described in note 12(a) in connection with the private placement. Each warrant is exercisable to purchase one common share at an exercise price of $0.50 per share until August 9, 2026. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.35, volatility 100%, risk-free rate 0.88%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $79,032. On January 29, 2021, the Company granted 3,350,000 common share purchase warrants as part of a non-brokered private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.25 per share until January 29, 2026. During the year ended November 30, 2021, 30,000 warrants were exercised at $0.25 per share. On January 29, 2021, the Company also granted 222,400 warrants to finders in connection with the private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.50 per share until August 9, 2026. During the year ended November 30, 2021, 4,240 warrants were exercised at $0.25 per share. The fair value was estimated using the Black-Scholes pricing model with estimated stock price of $0.52, volatility 100%, risk-free rate 0.43%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $95,395. Share purchase warrant transactions and the number of share purchase warrants outstanding as of November 30, 2023, November 30, 2022, and November 30, 2021, are summarized as follows: Number of Warrants Weighted Average Exercise Price Balance, November 30, 2021 9,991,241 $ 0.42 Warrants expired (561,081 ) 0.20 Balance, November 30, 2022 9,430,160 0.42 Granted 47,425,700 0.10 Balance, November 30, 2023 56,855,860 $ 0.14 The following summarizes the stock warrants outstanding at November 30, 2023: Expiry Date Exercise $ Number of Weighted average Weighted $ January 29, 2026 0.25 3,188,160 0.12 0.01 March 27, 2026 0.10 7,400,000 0.30 0.01 March 30, 2026 0.10 29,128,000 1.19 0.05 August 9, 2026 0.50 6,242,000 0.30 0.05 July 24, 2028 0.10 10,897,700 0.89 0.02 56,855,860 2.80 0.14

FINANCIAL RISK MANAGEMENT

FINANCIAL RISK MANAGEMENT	12 Months Ended
	Nov. 30, 2023
Disclosure Of Financial Risk Management Explanatory [Abstract]
FINANCIAL RISK MANAGEMENT [Text Block]	13. FINANCIAL RISK MANAGEMENT The Company's financial assets consist of cash, and due from related parties. The estimated fair values of cash, subscription receivable, and due from related parties approximate their respective carrying values due to the short period to maturity. Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The three levels of the fair value hierarchy are: a. Level 1 - unadjusted quoted prices in active markets for identical assets or liabilities. b. Level 2 - inputs other than quoted prices that are observable for the asset or liability either directly or indirectly; and c. Level 3 - inputs that are not based on observable market data. For the years ended November 30, 2023, and November 30, 2022, the fair value of the cash, accounts receivable, accounts payable, and due from related parties approximate the book value due to the short-term nature. The Company is exposed to a variety of financial instrument-related risks. The Board approves and monitors the risk management processes, inclusive of counterparty limits, controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows: Liquidity Risk Liquidity risk is the risk that the Company will not be able to meet its financial obligations when they become due. The Company ensures, as far as reasonably possible, it will have sufficient capital in order to meet short-term business requirements, after taking into account cash flows from operations and the Company's holdings of cash. The Company believes that these sources will be sufficient to cover the likely short-term cash requirements. The Company's cash is currently invested in business accounts which are available on demand by the Company for its operations. Interest Rate Risk Interest rate risk is the risk that future cash flows will fluctuate as a result of changes in market interest rates. The Company has no significant interest rate risk due to the short-term nature of its interest generating assets. Credit Risk Credit risk is the risk of a loss when a counterparty to a financial instrument fails to meet its contractual obligations. The Company's exposure to credit risk is limited to its cash. The Company limits its exposure to credit risk by holding its cash in deposits with high credit quality Canadian financial institutions. Foreign Currency Risk The Company is exposed to foreign currency risk on fluctuations related to cash, leases due from related parties and accounts payable and accrued liabilities that are denominated in US dollars. 10% fluctuations in the US dollar and UK Sterling Pound against the Canadian dollar have affected comprehensive loss for the period by approximately $20,587 (2022 - $7,464 and 2021 - $26,633).

SUPPLEMENTAL CASH FLOW INFORMAT

SUPPLEMENTAL CASH FLOW INFORMATION	12 Months Ended
	Nov. 30, 2023
Supplemental Cash Flows Information Abstract
SUPPLEMENTAL CASH FLOW INFORMATION [Text Block]	14. During the years ended November 30, 2023, 2022 and 2021, the Company has the following non-cash investing and financing activities: For the years ended November 30, November 30, November 30, Non-cash financing activities: Fair value of options granted and vested $ 99,588 $ 17,189 $ 1,144,342 Fair value of options exercised - - 158,106 Fair value of warrants granted 149,340 - 174,427 Fair value of warrants exercised - - 36,859 Shares issued to finders - - 100,500 Shares issued as compensation 169,000 17,189 307,734 For the years ended November 30, November 30, November 30, Cash payments for: Interest $ 6,238 $ - $ - Taxes - - -

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Nov. 30, 2023
Commitments And Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES [Text Block]	15. The Company has certain commitments related to key management compensation (management fees) for $10,000 per month with no specific expiry of terms (Note 9). During the year ended November 30, 2023, the Company, entered into joint venture agreements ("JVA") with third parties for the purpose of exploring opportunities to incorporate unmanned aerial vehicles/drones and docking stations with a software and with the vehicle-mounted solution. To the date of this report, the JVAs have yet to produce a product under these agreements and are under negotiation. Hence, no material transactions have been recognized in relation to these JVAs in the financial statements. One of the third parties initially cancelled the agreements on February 16, 2024. Subsequently, the Company and the said third party have been in discussions surrounding all existing agreements. As of report date, there is no conclusion yet on the negotiations between the parties.

RIGHT-OF-USE ASSETS AND LEASE L

RIGHT-OF-USE ASSETS AND LEASE LIABILITY	12 Months Ended
	Nov. 30, 2023
Right Of Use Assets And Lease Liability [Abstract]
RIGHT-OF-USE ASSETS AND LEASE LIABILITY [Text Block]	16. Right-of-use assets In November 2018, the Company's previously controlled subsidiary, PRT USA, entered into a two-year lease agreement for leased premises in Plymouth, Massachusetts, commencing December 1, 2018, and ending on November 30, 2020. On December 31, 2020, the Company renewed this lease agreement to November 30, 2023. The minimum base rent for the remaining lease term is USD$3,005 ($3,726) per month from December 1, 2019, to November 01, 2020; USD$3,095 ($3,838) per month from December 1, 2020, to November 30, 2021; USD$3,188 ($3,953) per month from December 1, 2021 to November 30, 2022; and USD$3,284 ($4,072) per month from December 1, 2022 to November 30, 2023. However, PRT USA agreed to terminate their lease with an arm's length party on December 31, 2022. On September 9, 2021, the Company's previously controlled subsidiary, PRT UK, entered into lease agreement with arm's length party to use the premises known as The Old Workshop, Estuary Road, King's Lynn, Norfolk from May 1, 2021 and will set to expire on April 30, 2024, with annual lease fee of £12,000 or £1,000 per month with interest of 4% per annum above Barclays Bank PLC base rate in case of default (Note 3) During the year ended November 30, 2023, the Company has disposed of its UK and US subsidiaries (Note 3) Accordingly, the ROU asset and lease liabilities have been derecognized. The following is the continuity of the cost and accumulated depreciation of right-of-use assets, for the year ended November 30, 2023, and for the year ended November 30, 2022: Balance, November 30, 2021 $ 72,734 Additions 38,027 Amortization expense (50,571 ) Cumulative translation adjustment 1,008 Balance, November 30, 2022 $ 61,198 Cumulative translation adjustment 1,677 Disposal of net liabilities due to loss of control (62,875 ) Balance, November 30, 2023 $ - Lease liabilities The following is the continuity of lease liability, for the years ended November 30, 2023, and 2022: Balance, November 30, 2021 $ 86,346 Additions 38,027 Lease payments (72,727 ) Interest on lease liability 18,877 Cumulative translation adjustment 5,274 Balance, November 30, 2022 $ 75,797 Cumulative translation adjustment 145 Disposal of net liabilities due to loss of control (75,942 ) Balance, November 30, 2023 $ - As at November 30, 2023, and November 30, 2022, the minimum lease payments for the lease liabilities are as follows: November 30, 2023 November 30, 2022 Year ending: 2023 $ - $ 72,664 2024 - 9,716 Subtotal - 82,380 Less: Interest expense on lease liabilities - (6,583 ) Total present value of minimum lease payments $ - $ 75,797

BREAKDOWN OF EXPENSES

BREAKDOWN OF EXPENSES	12 Months Ended
	Nov. 30, 2023
Disclosure of attribution of expenses by nature to their function [abstract]
BREAKDOWN OF EXPENSES [Text Block]	17. Years Ended November 30 General and Administrative Expenses Note 2023 2022 2021 Accounting and audit fees 9 $ 92,723 $ 192,403 $ 73,202 Consulting fees 9 136,475 138,523 328,805 Investor relations 261,908 - - General office expenses 20,209 31,160 13,033 Insurance 11,180 16,065 11,401 Legal fees 224,140 51,603 152,144 Management fees 9 92,127 - 118,000 Rent 6,000 6,963 10,726 Salaries and benefits 9 54,100 330,337 313,626 Stock-based compensation 9, 12 99,588 - 1,144,342 Transfer agent and filing fees 12 63,912 59,385 80,310 Travel 8,212 Total $ 1,070,574 $ 826,439 $ 2,245,589 Business development expenses amounting to $386,991 (2022 - $114,665; 2021 - $508,545) relate to corporate marketing and strategic investment initiatives done by the Company to build new businesses.

SEGMENTED INFORMATION

SEGMENTED INFORMATION	12 Months Ended
	Nov. 30, 2023
Disclosure of operating segments [abstract]
SEGMENTED INFORMATION [Text Block]	18. Following the loss of control of subsidiaries (Note 3) during the year ended November 30, 2023, the Company operates in one business segment, focusing on drone management and automation services as described in Note 1. Reportable segments are defined as components of an enterprise about which discrete financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Nov. 30, 2023
Income taxes paid (refund) [abstract]
INCOME TAXES [Text Block]	19. The following table reconciles the expected income taxes expense (recovery) at the Canadian statutory income tax rates to the amounts recognized in the statement of operations and comprehensive loss for the years ended November 30, 2023, 2022 and 2021: 2023 2022 2021 Net loss before tax and comprehensive loss $ (608,928 ) $ (2,667,798 ) $ (4,974,834 ) Statutory tax rate 27% 27% 27% Expected income tax (recovery) $ (164,000 ) $ (720,000 ) $ (1,343,000 ) Permanent differences (185,000 ) 617,000 985,000 Non-deductible items and others 1,848,000 1,436,000 1,331,000 Share issuance costs 63,000 - - Change in deferred tax assets not recognized (1,562,000 ) (1,333,000 ) (973,000 ) Income tax expense (recovery) $ - $ - $ - Significant components of the Company's unrecognized deferred tax assets (liabilities) for the years ended November 30, 2023, and 2022 are shown below: 2023 2022 Non-capital losses $ 1,745,000 $ 1,367,000 Capital losses 21,000 21,000 Share issuance costs 82,000 48,000 Unrecognized deferred tax assets (1,848,000 ) (1,436,000 ) Net deferred tax assets $ - $ - Non-capital losses carryforward The Company has non-capital loss carryforwards and net operating losses, for which no deferred tax asset has been recognized of approximately $6,464,410 (2022 - $5,061,190) which may be carried forward to apply against future income of the Company, subject to the final determination by taxation authorities, expiring in the following years: Expiry November 30, 2023 2038 $ 675,203 2039 941,464 2040 1,561,728 2041 1,412,265 2042 470,530 2043 1,403,221 Total $ 6,464,410

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Nov. 30, 2023
Disclosure of non-adjusting events after reporting period [abstract]
SUBSEQUENT EVENTS [Text Block]	20. On December 1, 2023, the Company entered into a consulting service agreement with third party requiring the latter to render business advisory and consulting services of up to 50 hours per month with monthly compensation of $3,500 and 1,560,000 Free trading Restricted Stock Units (RSUs) over the course of 6 months issued at the market price on the contract signing date. On December 20, 2023, the Company entered into a 90-day loan agreement with a Director amounting to $5,000 with interest of 10% per annum. On March 19, 2024, the terms were amended to extend the loan repayment date to June 19, 2024. On January 8, 2024, the Company entered into a 90-day loan agreement with a third party amounting to $5,000 with interest of 10% per annum. On April 7, 2024, the terms were amended to extend the loan repayment date to July 7, 2024. On March 5, 2024, pursuant to the facility agreements with a third party, the Company issued a conversion notice to borrower requiring the latter to convert the principal amount of $205,939 (£120,000) plus estimated accrued interest of $6,360 (£3,716) as at the date of this notice into fully paid ordinary shares in the capital of IDI. As of the date of this report, the shares have not been issued and the previously agreed upon conversion rate is still under negotiations with IDI. On March 14, 2024, the Company announced the non-brokered private placement financing of up to 10,000,000 units (the "Units") of securities at a price of $0.05 CAD per Unit for aggregate gross proceeds of up to $500,000.00 (the "Offering"). Each Unit is comprised of one (1) common share and one (1) fully transferable purchase warrant, with each whole warrant entitling the holder to purchase one additional common share at a price of $0.10 for five (3) years from the closing of the Offering. Finder's fee may be payable on a portion of the offering at the discretion of the Company. On March 15, 2024, the Company entered into a 90-day loan agreement with a third party amounting to $5,000 with interest of 10% per annum. On March 28, 2024, the Company entered into a 90-day loan agreement with a third party amounting to $5,000 with interest of 10% per annum. On April 10, 2024, the Company entered into a 90-day loan agreement with a third party amounting to $20,000 with interest of 10% per annum. On April 11, 2024, the Company entered into a 60-day loan agreement with its Chairman of the Board amounting to $9,636 (US $7,000) with interest of 10% per annum. On April 30, 2024, the Company entered into a 60-day loan agreement with a third party for $30,000 with interest of 12% per annum. The loan includes an option to convert into common shares of the Company equal to 100% of the principal amount of the loan plus all outstanding interest at the lowest price per share allowable under the policies of the CSE. The Company will issue a loan bonus of 50,000 commons shares to the lender. On April 30, 2024, 200,000 stock options with exercise price of $0.05 were cancelled. On May 1, 2024, the Company entered into a 60-day loan agreement with a third party for $15,000 with interest of 10% per annum. On May 3, 2024, the Company entered into a 60-day loan agreement with a third party for $20,000 with interest of 10% per annum.

MATERIAL ACCOUNTING POLICIES (P

MATERIAL ACCOUNTING POLICIES (Policies)	12 Months Ended
	Nov. 30, 2023
Notes to Financial Statements [Abstract]
Basis of presentation [Policy Text Block]	Basis of presentation These consolidated financial statements ("Financial Statements") have been prepared using accounting policies consistent with IFRS as issued by the International Accounting Standard Board ("IASB") and interpretations of the International Financial Reporting Interpretations Committee ("IFRIC"). These Financial Statements are authorized for issue by the Board of Directors on May 15, 2024. These Financial Statements have been prepared on the historical cost basis. In addition, these Financial Statements have been prepared using the accrual basis of accounting. These Financial Statements are presented in Canadian dollars, which is the Company's functional currency. The functional currency of PRT USA is U.S. Dollars and the functional currency of PRT UK and Tetra is British Pound Sterling ("£"). The assets and liabilities of PRT USA, PRT UK and Tetra are translated into Canadian dollars at the rate of exchange prevailing at the reporting date and their income and expense items are translated at average exchange rates for the period. Exchange differences arising on the translation are recognized in other comprehensive income.
Critical accounting judgments, estimates and assumptions [Policy Text Block]	Critical accounting judgments, estimates and assumptions The preparation of these Financial Statements in conformity with IFRS requires management to make judgments and estimates and form assumptions that affect the reported amounts of assets and liabilities at the date of the Financial Statements and reported amounts of income and expenses during the period. Actual results could differ from these estimates. Significant estimates used in preparing the Financial Statements include, but are not limited to the following: a. The calculation of deferred tax is based on the ability of the Company to generate future taxable income, the estimation of which is subject to significant uncertainty as to the amount and timing. The calculation of deferred tax is also based on assumptions, which are subject to uncertainty as to timing and which tax rates are expected to apply when temporary differences reverse. Deferred tax recorded is also subject to uncertainty regarding the magnitude on non-capital losses available for carry forward and of the balances in various tax pools as the corporate tax returns have not been prepared as of the date of financial statement preparation. b. The fair value of stock options and finders' warrants issued are subject to the limitations of the Black-Scholes option pricing model that incorporates market data and involves uncertainty in estimates used by management in the assumptions. Because the Black-Scholes option pricing model requires the input of highly subjective assumptions, including the expected lift, volatility of share prices, risk-free rate and dividend yield, changes in subjective input assumptions can materially affect the fair value estimate. c. Impairment exists when the carrying value of an asset or cash generating unit ("CGU") exceeds its recoverable amount, which is the higher of its fair value less costs to sell and its value in use. The fair value less costs to sell calculation is based on available data from binding sales transactions in an arm's length transaction of similar assets or observable market prices less incremental costs for disposing of the asset. The value in use calculation is based on a discounted cash flow model. d. Management uses estimation in determining the incremental borrowing rate used to measure the lease liability, specific to the asset, underlying currency and geographic location. Significant judgments used in the preparation of these Financial Statements include, but are not limited to the following: (i) Management has applied judgements in the assessment of the Company's ability to continue as a going concern when preparing its Financial Statements for the year ended November 30, 2023. Management prepares the Financial Statements on a going concern basis unless management either intends to liquidate the entity or to cease trading or has no realistic alternative but to do so. In assessing whether the going concern assumption is appropriate, management accounts for all available information about the future, which is at least, but is not limited to, twelve months from the issuance of the financial statements. (ii) Determination of whether a set of assets acquired, and liabilities assumed constitute the acquisition of a business or asset may require the Company to make certain judgments as to whether or not the assets acquired, and liabilities assumed include the inputs, processes and outputs necessary to constitute a business as defined in IFRS 3 - Business Combinations. Based on an assessment of the relevant facts and circumstances, the Company concluded that the acquisition disclosed in Note 3 met the criteria for accounting as a business combination.
Cash [Policy Text Block]	Cash Cash consists of amounts held in banks and highly liquid investments with limited interest and credit risk.
Consolidation [Policy Text Block]	Consolidation The Financial Statements include the accounts of the Company and its wholly owned subsidiaries up to the date the Company had control (Note 3). Control exists when the Company has the power and ability, directly or indirectly, to direct the relevant activities of an entity to obtain benefit from its activities. Subsidiaries are fully consolidated from the date that control commences until the date the control ceases. The accounting policies of the Company's subsidiaries have been aligned with the policies adopted by the Company. When the Company ceases to control a subsidiary, the financial statements of the subsidiary are de-consolidated (Note 3).
Equipment [Policy Text Block]	Equipment Recognition and measurement On initial recognition, equipment is valued at cost, being the purchase price and directly attributable cost of acquisition or construction required to bring the asset to the location and condition necessary to be capable of operating in the manner intended by the Company, including appropriate borrowing costs and the estimated present value of any future unavoidable costs of dismantling and removing the items. The corresponding liability is recognized within provisions. Equipment is subsequently measured at cost less accumulated depreciation, less any accumulated impairment losses. When parts of an item of equipment have different useful lives, they are accounted for as separate items (major components) of equipment. Gains and losses Gains and losses on disposal of an item of equipment are determined by comparing the proceeds from disposal with the carrying amount and are recognized net within other income in profit or loss. Depreciation Half of the normal depreciation is taken in the year of acquisition for equipment with declining balance method. The depreciation rates applicable to each category of property and equipment are as follows: Computer equipment 55% declining balance Vehicles 30% declining balance Furniture 20% declining balance Leasehold improvements 30% declining balance Demo equipment 20% declining balance
Inventories [Policy Text Block]	Inventories The Company values inventories at the lower of cost and net realizable value. Cost includes the costs of purchases net of vendor allowances plus other costs, such as transportation, that are directly incurred to bring the inventories to their present location and condition.
Business combinations [Policy Text Block]	Business combinations Business combinations are accounted for using the acquisition method. The cost of the acquisition is measured at the aggregate of the fair values at the date of acquisition, of assets transferred, liabilities incurred or assumed, and equity instruments issued by the Company. The acquiree's identifiable assets and liabilities assumed are recognized at their fair value at the acquisition date. Acquisition-related costs are recognized in profit or loss as incurred. The excess of consideration over the fair value of the net identifiable assets and liabilities acquired is recorded as goodwill. Any gain on a bargain purchase is recorded in profit or loss immediately. Transaction costs are expensed as incurred, except if related to the issue of debt or equity securities. Any goodwill that arises is tested annually for impairment.
Share capital [Policy Text Block]	Share capital The Company records proceeds from the issuance of its common shares as equity. Proceeds received on the issuance of units, consisting of common shares and warrants, are allocated between the common share and warrant component. The Company has adopted a residual value method with respect to the measurement of shares and warrants issued as private placement units. The residual value method first allocates value to the most easily measurable component based on fair value and then the residual value, if any, to the less easily measurable component. The fair value of the common shares issued in the private placement was determined to be the more easily measurable component and were valued at their fair value, as determined by the closing quoted price on the issuance date. The remaining proceeds, if any, are allocated to the attached warrants. Any fair value attributed to the warrants is recorded as warrant reserve. Management does not expect to record a value to the warrant in most equity issuances as unit private placements are commonly priced at market or at a permitted discount to market. If the warrants are issued as share issuance costs, the fair value of agent's warrants are measured using the Black-Scholes option pricing model and recognized in equity as a deduction from the proceeds. If the warrants are exercised, the related amount is reclassified as share capital. If the warrants expire unexercised, the related amount remains in warrant reserve. Incremental costs directly attributable to the issue of new common shares are shown in equity as a deduction, net of tax, from the proceeds. Common shares issued for consideration other than cash are valued based on their market value at the date that shares are issued.
Stock-based payment [Policy Text Block]	Stock-based payment The Company recognizes share-based payment expense for the estimated fair value of equity-based instruments granted to both employees and non-employees. Compensation expense is recognized when the options are granted with the same amount being recorded as contributed surplus. The expense is determined using an option pricing model that accounts for the exercise price, the term of the option, the current share price, the expected volatility of the underlying shares, the expected dividend yield, and the risk-free interest rate for the term of the option. If the options are exercised, the contributed surplus will be reduced by the applicable amount. Share-based payment calculations have no effect on the Company's cash position.
Earnings (loss) per share [Policy Text Block]	Earnings (loss) per share Basic earnings (loss) per share are calculated using the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are calculated using the treasury stock method. This method for diluted earnings (loss) per share assumes that common shares are issued for the exercise of options, warrants and convertible securities and that the assumed proceeds from the exercise of options, warrants and convertible securities are used to purchase common shares at the average market price during the period. The difference between the number of shares assumed issued and the number of shares assumed purchased is then added to the basic weighted average number of shares outstanding to determine the fully diluted number of common shares outstanding. No calculation of diluted earnings (loss) per shares is assumed during the periods in which a net loss is incurred as the effect is anti-dilutive.
Financial instruments [Policy Text Block]	Financial instruments Financial assets a) The Company classifies its financial instruments in the following categories: at fair value through profit and loss ("FVTPL"), at fair value through other comprehensive income (loss) ("FVTOCI") or at amortized cost. The Company determines the classification of financial assets at initial recognition. The classification of debt instruments is driven by the Company's business model for managing the financial assets and their contractual cash flow characteristics. Equity instruments that are held for trading are classified as FVTPL. For other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument-by-instrument basis) to designate them as at FVTOCI. Financial liabilities are measured at amortized cost, unless they are required to be measured at FVTPL (such as instruments held for trading or derivatives) or if the Company has opted to measure them at FVTPL. b) Financial assets and liabilities at amortized cost Financial assets and liabilities at amortized cost are initially recognized at fair value plus or minus transaction costs, respectively, and subsequently carried at amortized cost less any impairment. The Company's financial assets measured at amortized cost are comprised of its cash and trade and other receivables, net. The Company's financial liabilities measured at amortized cost are comprised of its accounts payable and accrued liabilities, loans payable, loans payable - related party, convertible debt, convertible debt - related parties, silent partnerships, silent partnerships - related party and lease liabilities. Financial assets and liabilities at FVTPL Financial assets and liabilities carried at FVTPL are initially recorded at fair value and transaction costs are expensed in the statements of loss and comprehensive loss. Realized and unrealized gains and losses arising from changes in the fair value of the financial assets and liabilities held at FVTPL are included in the statements of loss and comprehensive loss in the period in which they arise. Debt instruments at FVTOCI These assets are initially measured at fair value. Interest income calculated using the effective interest method, foreign exchange gains and losses and impairment are recognized in profit or loss. Other net gains and losses associated with changes in fair value are recognized in OCI. On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss. The Company does not hold any debt instruments at FVTOCI. Equity instruments at FVTOCI These assets are initially measured at fair value. Dividends are recognized as income in profit or loss unless the dividend clearly represents a recovery of part of the cost of the investment. Other net gains and losses associated with changes in fair value are recognized in OCI and are never reclassified to profit or loss. The Company does not hold any equity instruments at FVTOCI. c) The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the Company measures the loss allowance for the financial asset at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date the financial asset has not increased significantly since initial recognition, the Company measures the loss allowance for the financial asset at an amount equal to the twelve month expected credit losses. The Company shall recognize in the statements of loss and comprehensive loss, as an impairment gain or loss, the amount of expected credit losses (or reversal) that is required to adjust the loss allowance at the reporting date to the amount that is required to be recognized. d) Financial assets The Company derecognizes financial assets only when the contractual rights to cash flow from the financial assets expire, or when it transfers the financial assets and substantially all of the associated risks and rewards of ownership to another entity. Financial liabilities The Company derecognizes financial liability when its contractual obligations are discharged or cancelled or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are generally recognized in profit or loss. The Company applies the simplified approach for accounts receivable that do not contain a significant financing component. Using the simplified approach, the Company records a loss allowance equal to the expected credit losses resulting from all possible default events over the assets' contractual lifetime. Financial assets are written off when the Company has no reasonable expectations of recovering all or any portion thereof. The Company derecognizes a financial asset when its contractual rights to the cash flows from the financial asset expire. Interest Interest income and expense are recognized in profit or loss using the effective interest method. The 'effective interest rate' is the rate that exactly discounts estimated future cash payments over the expected life of the financial instrument to the gross carrying amount of the financial asset or the amortized cost of the financial liability. The effective interest rate is calculated considering all contractual terms of the financial instruments, except for the expected credit losses of financial assets. The 'amortized cost' of a financial asset or financial liability is the amount at which the instrument is measured on initial recognition minus principal repayments, plus or minus any cumulative amortization using the effective interest method of any difference between the initial amount and maturity amount and adjusted for any expected credit loss allowance. The 'gross carrying amount' of a financial asset is the amortized cost of a financial asset before adjusting for any expected credit losses. Interest income and expense is calculated by applying the effective interest rate to the gross carrying amount of the financial asset (when the asset is not credit-impaired) or the amortized cost of the financial liability. Where a financial asset has become credit-impaired subsequent to initial recognition, interest income is calculated in subsequent periods by applying the effective interest method to the amortized cost of the financial asset. If the asset subsequently ceases to be credit-impaired, calculation of interest income reverts to a gross basis. Offsetting Financial assets and financial liabilities are offset, with the net amount presented in the statement of financial position, when, and only when, the Company has a current and legally enforceable right to set off the recognized amounts and intends either to settle on a net basis or realize the asset and settle the liability simultaneously. Income and expenses are presented on a net basis only when permitted under IFRS, or when arising from a group of similar transactions if the resulting income and expenses are not material.
Revenue recognition [Policy Text Block]	Revenue recognition Revenue is recognized by applying the five-step model under IFRS 15. The Company recognizes revenue when, or as the goods or services are transferred to the control of the customer and performance obligations are satisfied. The Company's revenue is comprised of sales of its radar systems, radar components and engineering design and development services. The Company's revenue is recognized when control of the goods has been transferred, when the goods are delivered to customers and when all performance obligations have been fulfilled. The amounts recognized as revenue represent the fair values of the considerations received or receivable from third parties on the sales of goods to customers, net of goods and services taxes and less returns, and discounts, at which time there are no conditions for the payment to become due other than the passage of time. For its engineering design and development services, revenue is recognized when the service has been rendered.
Deferred revenue [Policy Text Block]	Deferred revenue The Company recognizes deferred revenue when the customers pay in advance for the goods or services to be delivered in future periods. Revenue will be recognized in the future period when the goods and services are provided and in accordance with IFRS 15.
Government grants [Policy Text Block]	Government grants Government grants are recognized at fair value once there is reasonable assurance that the Company will comply with the conditions attached to the grants and that the grants will be received. Government grants are recognized in profit or loss on a systematic basis over the periods in which the Company recognizes as expenses the related costs for which the grants are intended to compensate. A forgivable loan from the government is treated as a government grant when there is reasonable assurance that the entity will meet the terms for forgiveness of the loan.
Income taxes [Policy Text Block]	Income taxes Income tax is recognized in profit or loss except to the extent that it relates to equity items, in which case it is recognized in equity. Current tax expense is the expected tax payable on the taxable income for the year, using tax rates enacted at period end, adjusted for amendments to tax payable with regards to previous years. Deferred tax is recorded using the liability method, providing for temporary differences, between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. The following temporary differences do not result in deferred tax assets or liabilities: goodwill not deductible for tax purposes; the initial recognition of assets or liabilities that affect neither accounting profit (loss) nor taxable profit (loss); and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the financial position date. A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized. Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when they relate to income taxes levied by the same taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis.
Related party transactions [Policy Text Block]	Related party transactions Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control and related parties may be individuals or corporate entities. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.
Leases [Policy Text Block]	Leases The Company adopted IFRS 16 effective December 1, 2019. The Company chose to adopt the modified retrospective approach on transition to IFRS 16 and has chosen not to restate comparative information in accordance with the transitional provisions in IFRS 16. As a result, the comparative information continues to be presented in accordance with the Company's previous accounting policies. The adoption of IFRS 16 resulted in the recognition of a right-of-use asset and a lease liability measured at the present value of the future lease payments on the consolidated statements of financial position. An amortization expense on the right-of-use asset and an interest expense on the lease liability has replaced the operating lease expense. IFRS 16 has changed the presentation of cash flows relating to leases in the Company's consolidated statements of cash flows, however, it does not cause a difference in the amount of cash transferred between the parties of the lease.
Subsidiaries [Policy Text Block]	Subsidiaries Subsidiaries are entities controlled by the Company. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. The financial statements of subsidiaries are included in the consolidated financial statements from the date on which control commences until the date on which control ceases. Where necessary, adjustments are made to the financial statements of subsidiaries to bring their accounting policies in line with those adopted by the Company. Changes in the Company's interest in a subsidiary that do not result in a loss of control are accounted for as equity transactions.
Loss of control [Policy Text Block]	Loss of control When the Company loses control over a subsidiary, it derecognizes the assets and liabilities of the subsidiary, and any related NCI and other components of equity. Any resulting gain or loss is recognized in the consolidated statement of operations. Any interest retained in the former subsidiary is measured at fair value when control is lost.
Discontinued operations [Policy Text Block]	Discontinued operations The Company classifies a component of the reporting entity is disposed of as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on a reporting entity's operations and financial results. Such disposal groups are measured at the lower of their carrying amount and fair value less costs to sell. A disposal Company qualifies as discontinued operations if it is a component of an entity that either has been disposed of, or is classified as held for sale, and: • Represents a separate major line of business or geographical area of operations. • Is part of a single coordinated plan to dispose of a separate major line of business or geographical area of operations. • Is a subsidiary acquired exclusively with a view to re‐sell Loss from discontinued operations is excluded from net loss from continuing operations and are presented as a single amount under "loss from discontinued operations" account in the consolidated statement of loss and comprehensive loss.
Accounting standards, amendments and interpretations not yet effective [Policy Text Block]	Accounting standards, amendments and interpretations not yet effective Certain new standards, interpretations and amendments to existing standards have been issued by the IASB or the IFRIC during the period but are not yet effective. Some updates that are not applicable or are not consequential to the Company may have been excluded from the list below. IAS 1 - Classification of Liabilities as Current or Noncurrent existence at the end of the reporting period, specify that classification is unaffected by expectations about whether an entity will exercise its right to defer settlement of a liability, explain that rights are in existence if covenants are complied with at the end of the reporting period, and introduce a definition of 'settlement' to make clear that settlement refers to the transfer to the counterparty of cash, equity instruments, other assets or services. The amendments are effective for annual reporting periods beginning on or after January 1, 2023. Earlier adoption is permitted. IAS 16 - Proceeds before Intended Use These new and amended standards are not expected to have a material impact on the Company's Financial Statements

MATERIAL ACCOUNTING POLICIES (T

MATERIAL ACCOUNTING POLICIES (Tables)	12 Months Ended
	Nov. 30, 2023
Disclosure Of Significant Accounting Policies [Abstract]
Disclosure of depreciation rates applicable to each category of property and equipment [Table Text Block]	Computer equipment 55% declining balance Vehicles 30% declining balance Furniture 20% declining balance Leasehold improvements 30% declining balance Demo equipment 20% declining balance

DISCONTINUED OPERATIONS - LOS_2

DISCONTINUED OPERATIONS - LOSS OF CONTROL (Tables)	12 Months Ended
	Nov. 30, 2023
Disclosure of analysis of single amount of discontinued operations [line items]
Disclosure of gain (loss) from discontinued operations [Table Text Block]	Year ended November 30 2023 2022 2021 Net Gain (Loss) from discontinued operations - loss of control $ 995,142 $ (1,949,330 ) $ (2,191,326 )
Disclosure of results of operations of discontinued operations [Table Text Block]	For the years ended November 30 2023 2022 2021 Sales $ - $ 607,359 $ 184,396 Cost of sales - (191,175 ) (103,109 ) Gross Profit - 416,184 81,287 OPERATING EXPENSES General and administrative - 1,519,539 1,074,492 Business development - 62,763 200,465 Research and development - 233,264 985,006 Total expenses - 1,815,566 2,259,963 OTHER INCOME (EXPENSES) Impairment loss on Demo Equipment - (236,677 ) - Impairment of intangible asset - (330,650 ) - Other Income - 5,042 - Gain on debt forgiveness - 11,532 - Foreign exchange gain (loss) - 805 (12,650 ) Total other income (expense) - (549,948 ) (12,650 ) Loss from discontinued operations $ - $ (1,949,330 ) $ (2,191,326 )
Disclosure of gain from loss of control of subsidiaries [Table Text Block]	PRT USA PRT UK Tetra Drones Total Net liabilities before loss of control of subsidiaries $ 4,870,623 $ 1,481,194 $ 227,907 $ 6,579,724 Foreign currency translation adjustments (123,484 ) 25,310 3,023 (95,151 ) Less: Receivables from subsidiaries (4,248,018 ) (1,120,913 ) (120,500 ) (5,489,431 ) Gain from loss of control of subsidiaries $ 499,121 $ 385,591 $ 110,430 $ 995,142
PRT USA [Member]
Disclosure of analysis of single amount of discontinued operations [line items]
Disclosure of net assets and liabilities of discontinued operations [Table Text Block]	As at December 1, 2022 ASSETS Current Assets Cash, cash equivalents, and restricted cash $ 9,700 Prepaid expenses 8,313 Account receivable 6,831 Inventories 2,163 Total current assets of discontinued operations 27,007 Non-current assets Equipment 5,919 Right of use asset 38,189 Total non-current assets of discontinued operations 44,108 Assets of discontinued operations $ 71,115 LIABILITIES Liabilities Accounts payable $ 284,181 Lease liability 671,205 Due to related parties 4,608,071 Liabilities of discontinued operation 4,941,738 Carrying value of net liabilities immediately prior to loss of control of subsidiary $ 4,870,623 Receivable from PRT USA (4,248,018 ) Reclassification of foreign currency translation (123,484 ) Gain from loss of control of PRT USA $ 499,121
PRT UK [Member]
Disclosure of analysis of single amount of discontinued operations [line items]
Disclosure of net assets and liabilities of discontinued operations [Table Text Block]	As at December 1, 2022 ASSETS Current Assets Cash, cash equivalents, and restricted cash $ 3,852 Prepaid expenses 8,983 Total current assets of discontinued operations 12,835 Non-current assets Equipment 9,171 Right of use asset 24,686 Total non-current assets of discontinued operations 33,857 Assets of discontinued operations $ 46,692 LIABILITIES Current Liabilities Accounts payable $ 455,062 Current Lease Liability 26,456 Due to related parties 919,436 Deferred revenue 124,918 Liabilities of discontinued operations $ 1,527,886 Carrying value of net liabilities immediately prior to loss of control of subsidiary $ 1,481,194 Receivable from PRT UK (1,120,913 ) Foreign exchange gains 25,310 Gain from loss of control of PRT UK $ 385,591
Tetra Drones [Member]
Disclosure of analysis of single amount of discontinued operations [line items]
Disclosure of net assets and liabilities of discontinued operations [Table Text Block]	As at December 1, 2022 ASSETS Current Assets Sales tax receivable $ 435 Total current assets of discontinued operations 435 Non-current assets Equipment 9,982 Total non-current assets of discontinued operations 9,982 Assets of discontinued operations $ 10,417 LIABILITIES Current Liabilities Bank Overdraft $ 16,294 Accounts payable 12,043 Due to related parties 209,738 Loan payable - current 249 Liabilities of discontinued operations $ 238,324 Carrying value of net liabilities immediately prior to loss of control of subsidiary $ 227,907 Receivable from Tetra Drones (120,500 ) Foreign exchange gains 3,023 Gain from loss of control of Tetra Drones $ 110,430

PREPAID EXPENSES (Tables)

PREPAID EXPENSES (Tables)	12 Months Ended
	Nov. 30, 2023
Disclosure Of Detail Information About Prepaid Expenses [Abstract]
Disclosure of prepaid expenses [Table Text Block]	November 30, 2023 November 30, 2022 Advertising and promotions $ - $ 113 Investor relations 85,510 - Professional fees 7,469 - Consulting fees 80,000 - Rent - 8,247 Transfer agent and filing fees 7,143 13,748 Insurance 3,750 8,839 $ 183,872 $ 30,947

EQUIPMENT (Tables)

EQUIPMENT (Tables)	12 Months Ended
	Nov. 30, 2023
Property, plant and equipment [abstract]
Disclosure of property, plant and equipment [Table Text Block]	Computer Furniture Vehicles Leasehold Improvement Demo Equipment Total $ $ $ $ $ $ Cost: Balance at November 30, 2021 24,028 19,271 16,014 3,826 239,747 302,886 Disposal - - (16,243 ) - - (16,243 ) Foreign currency translation adjustment (997 ) 190 229 (182 ) 3,158 2,398 Balance at November 30, 2022 23,031 19,461 - 3,644 242,905 289,041 Foreign currency translation adjustment 361 206 - 59 2,653 3,279 Disposals due to discontinued operations (23,392 ) (19,667 ) - (3,703 ) (245,558 ) (292,320 ) Balance at November 30, 2023 - - - - - - Accumulated Depreciation: Balance at November 30, 2021 1,716 5,473 1,218 291 - 8,698 Amortization 9,236 2,688 4,210 1,006 - 17,140 Disposal - - (5,375 ) - - (5,375 ) Impairment - - - - 236,677 236,677 Foreign currency translation adjustment 642 296 (53 ) (13 ) 6,228 7,100 Balance at November 30, 2022 11,594 8,457 - 1,284 242,905 264,240 Amortization 1,593 554 - 179 - 2,326 Foreign currency translation adjustment 180 81 - 23 2,653 2,937 Disposals due to discontinued operations (13,367 ) (9,092 ) - (1,486 ) (245,558 ) (269,503 ) Balance at November 30, 2023 - - - - - - Net Book Value: At November 30, 2022 11,437 11,004 - 2,360 - 24,801 At November 30, 2023 - - - - - -

ACCOUNTS PAYABLE (Tables)

ACCOUNTS PAYABLE (Tables)	12 Months Ended
	Nov. 30, 2023
Disclosure Of Detail Information About Accounts Payable [Abstract]
Disclosure of accounts payable [Table Text Block]	November 30, 2023 November 30, 2022 Professional fees $ 22,116 $ 382,805 Funds to be returned to investors 43,046 43,046 Advertising costs 2,520 34,705 Payroll - 268,610 Development costs - 168,925 Bank overdraft - 16,036 VAT Payable - 61,262 Purchases - 2,121 Rent - 1,822 Others 9,444 84,531 $ 77,126 $ 1,063,863

RELATED PARTY TRANSACTIONS AN_2

RELATED PARTY TRANSACTIONS AND BALANCES (Tables)	12 Months Ended
	Nov. 30, 2023
Related party transactions [abstract]
Disclosure of amounts due to directors and officers [Table Text Block]	November 30, 2023 November 30, 2022 Company controlled by the President and CEO $ 6,077 $ 78,750 Director and Chairman - 1,731 Former CFO of the Company - 67,540 Former interim CEO of the Company - 250,179 Former CEO and Director 361,573 307,472 Company controlled by a director 5,000 - $ 372,650 $ 705,672
Disclosure of transactions between related parties [Table Text Block]	November 30, 2023 November 30, 2022 November 30, 2021 Management fees $ 92,127 $ - $ 55,000 Consulting fees 47,500 135,000 307,734 Accounting fees 63,844 - 36,202 Professional fees 10,429 - - Stock-based compensation 57,425 - 410,132 Salaries and benefits 54,100 330,337 313,626 Others 7,144 - 5,000 $ 332,569 $ 465,337 $ 1,127,694
Disclosure of management fees [Table Text Block]	November 30, 2023 November 30, 2022 November 30, 2021 Company controlled by the President and CEO $ 35,000 $ - $ - CFO 30,000 - Former Interim CEO 27,127 - - Former CFO of the Company - - 55,000 $ 92,127 $ - $ 55,000
Disclosure of consulting fees [Table Text Block]	November 30, 2023 November 30, 2022 November 30, 2021 Company controlled by the President and CEO $ 47,500 $ 75,000 $ - Company controlled by the Former Corporate Secretary - 60,000 - Director - - 307,734 $ 47,500 $ 135,000 $ 307,734
Disclosure of professional fees [Table Text Block]	November 30, 2023 November 30, 2022 November 30, 2021 CFO and Former Corporate Secretary $ 1,000 $ - $ - Company controlled by the Corporate Secretary 9,429 - - $ 10,429 $ - $ -
Disclosure of stock options held by Directors and officers [Table Text Block]	November 30, 2023 November 30, 2022 November 30, 2021 Number of Options Expense for the Number of Expense Number of Expense CEO 800,000 $ 24,834 - $ - - $ - CFO 200,000 6,208 - - - - Corporate Secretary 50,000 1,552 - - - - Former CEO - - 600,000 - 600,000 $ 133,275 Former CFO - - 150,000 - 150,000 33,319 Former Corporate Secretary - - 150,000 - 150,000 33,319 Directors 800,000 24,868 750,000 - 825,000 210,219 1,850,000 $ 57,462 1,650,000* $ - 1,725,000 $ 410,132

SHARE CAPITAL (Tables)

SHARE CAPITAL (Tables)	12 Months Ended
	Nov. 30, 2023
Disclosure of classes of share capital [abstract]
Disclosure of number and weighted average exercise prices of share options [Table Text Block]	Number of Weighted Average Options Exercise Price Balance, November 30, 2021 4,225,000 $ 0.64 Expired (75,000 ) 0.50 Cancelled (125,000 ) 0.50 Balance, November 30, 2022 4,025,000 $ 0.66 Cancelled (3,900,000 ) 0.66 Granted 3,450,000 0.04 Balance, November 30, 2023 3,575,000 $ 0.06
Disclosure of number and weighted average remaining contractual life of outstanding share options [Table Text Block]	Expiry Date Exercise Price Numbers of options outstanding Numbers of options exercisable Weighted average remaining contractual life (year) Weighted average exercise price $ $ November 28, 2024 0.50 125,000 125,000 0.03 0.02 August 18, 2026 0.05 2,450,000 2,357,917 1.86 0.03 October 19, 2028 0.05 1,000,000 1,000,000 1.37 0.01 3,575,000 3,482,917 3.26 0.06
Disclosure of share purchase warrant transactions [Table Text Block]	Number of Warrants Weighted Average Exercise Price Balance, November 30, 2021 9,991,241 $ 0.42 Warrants expired (561,081 ) 0.20 Balance, November 30, 2022 9,430,160 0.42 Granted 47,425,700 0.10 Balance, November 30, 2023 56,855,860 $ 0.14
Disclosure of number of share purchase warrants outstanding [Table Text Block]	Expiry Date Exercise $ Number of Weighted average Weighted $ January 29, 2026 0.25 3,188,160 0.12 0.01 March 27, 2026 0.10 7,400,000 0.30 0.01 March 30, 2026 0.10 29,128,000 1.19 0.05 August 9, 2026 0.50 6,242,000 0.30 0.05 July 24, 2028 0.10 10,897,700 0.89 0.02 56,855,860 2.80 0.14

SUPPLEMENTAL CASH FLOW INFORM_2

SUPPLEMENTAL CASH FLOW INFORMATION (Tables)	12 Months Ended
	Nov. 30, 2023
Supplemental Cash Flows Information Abstract
Disclosure of supplemental cash flow information [Table Text Block]	For the years ended November 30, November 30, November 30, Non-cash financing activities: Fair value of options granted and vested $ 99,588 $ 17,189 $ 1,144,342 Fair value of options exercised - - 158,106 Fair value of warrants granted 149,340 - 174,427 Fair value of warrants exercised - - 36,859 Shares issued to finders - - 100,500 Shares issued as compensation 169,000 17,189 307,734 For the years ended November 30, November 30, November 30, Cash payments for: Interest $ 6,238 $ - $ - Taxes - - -

RIGHT-OF-USE ASSETS AND LEASE_2

RIGHT-OF-USE ASSETS AND LEASE LIABILITY (Tables)	12 Months Ended
	Nov. 30, 2023
Right Of Use Assets And Lease Liability [Abstract]
Disclosure of continuity of the cost and accumulated amortization of right-of-use assets [Table Text Block]	Balance, November 30, 2021 $ 72,734 Additions 38,027 Amortization expense (50,571 ) Cumulative translation adjustment 1,008 Balance, November 30, 2022 $ 61,198 Cumulative translation adjustment 1,677 Disposal of net liabilities due to loss of control (62,875 ) Balance, November 30, 2023 $ -
Disclosure of continuity of lease liability [Table Text Block]	Balance, November 30, 2021 $ 86,346 Additions 38,027 Lease payments (72,727 ) Interest on lease liability 18,877 Cumulative translation adjustment 5,274 Balance, November 30, 2022 $ 75,797 Cumulative translation adjustment 145 Disposal of net liabilities due to loss of control (75,942 ) Balance, November 30, 2023 $ -
Disclosure of minimum lease payments for the lease liabilities [Table Text Block]	November 30, 2023 November 30, 2022 Year ending: 2023 $ - $ 72,664 2024 - 9,716 Subtotal - 82,380 Less: Interest expense on lease liabilities - (6,583 ) Total present value of minimum lease payments $ - $ 75,797

BREAKDOWN OF EXPENSES (Tables)

BREAKDOWN OF EXPENSES (Tables)	12 Months Ended
	Nov. 30, 2023
Disclosure of attribution of expenses by nature to their function [abstract]
Disclosure of breakdown of expenses [Table Text Block]	Years Ended November 30 General and Administrative Expenses Note 2023 2022 2021 Accounting and audit fees 9 $ 92,723 $ 192,403 $ 73,202 Consulting fees 9 136,475 138,523 328,805 Investor relations 261,908 - - General office expenses 20,209 31,160 13,033 Insurance 11,180 16,065 11,401 Legal fees 224,140 51,603 152,144 Management fees 9 92,127 - 118,000 Rent 6,000 6,963 10,726 Salaries and benefits 9 54,100 330,337 313,626 Stock-based compensation 9, 12 99,588 - 1,144,342 Transfer agent and filing fees 12 63,912 59,385 80,310 Travel 8,212 Total $ 1,070,574 $ 826,439 $ 2,245,589

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Nov. 30, 2023
Income taxes paid (refund) [abstract]
Disclosure of detailed information about effective income tax expense (recovery) [Table Text Block]	2023 2022 2021 Net loss before tax and comprehensive loss $ (608,928 ) $ (2,667,798 ) $ (4,974,834 ) Statutory tax rate 27% 27% 27% Expected income tax (recovery) $ (164,000 ) $ (720,000 ) $ (1,343,000 ) Permanent differences (185,000 ) 617,000 985,000 Non-deductible items and others 1,848,000 1,436,000 1,331,000 Share issuance costs 63,000 - - Change in deferred tax assets not recognized (1,562,000 ) (1,333,000 ) (973,000 ) Income tax expense (recovery) $ - $ - $ -
Disclosure of temporary difference, unused tax losses and unused tax credits [Table Text Block]	2023 2022 Non-capital losses $ 1,745,000 $ 1,367,000 Capital losses 21,000 21,000 Share issuance costs 82,000 48,000 Unrecognized deferred tax assets (1,848,000 ) (1,436,000 ) Net deferred tax assets $ - $ -
Disclosure of non-capital loss carryforwards [Table Text Block]	Expiry November 30, 2023 2038 $ 675,203 2039 941,464 2040 1,561,728 2041 1,412,265 2042 470,530 2043 1,403,221 Total $ 6,464,410

NATURE OF OPERATIONS AND GOIN_2

NATURE OF OPERATIONS AND GOING CONCERN (Narrative) (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
Nature Of Operations And Ability To Continue As Going Concern Abstract
Comprehensive loss	$ 634,059	$ 2,739,060	$ 4,944,231
Accumulated deficit	17,144,688	$ 16,535,760
Net cash proceeds pursuant to financing activities	$ 1,965,998

MATERIAL ACCOUNTING POLICIES -

MATERIAL ACCOUNTING POLICIES - Disclosure of depreciation rates applicable to each category of property and equipment (Detail)	12 Months Ended
	Nov. 30, 2023
Computer equipment [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Depreciation rate	55%
Depreciation method	declining balance
Furniture [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Depreciation rate	20%
Depreciation method	declining balance
Demo equipment [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Depreciation rate	20%
Depreciation method	declining balance
Vehicles [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Depreciation rate	30%
Depreciation method	declining balance
Leasehold improvements [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Depreciation rate	30%
Depreciation method	declining balance

DISCONTINUED OPERATIONS - LOS_3

DISCONTINUED OPERATIONS - LOSS OF CONTROL (Narrative) (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
Disclosure of analysis of single amount of discontinued operations [line items]
Net liabilities before loss of control of subsidiaries	$ 6,579,724
Receivables	5,489,431
Gain from loss of control of subsidiaries	995,142	$ (1,949,330)	$ (2,191,326)
PRT USA [Member]
Disclosure of analysis of single amount of discontinued operations [line items]
Net liabilities before loss of control of subsidiaries	4,870,623
Receivables	4,248,018
Gain from loss of control of subsidiaries	499,121	0
PRT UK [Member]
Disclosure of analysis of single amount of discontinued operations [line items]
Net liabilities before loss of control of subsidiaries	1,481,194
Receivables	1,120,913
Gain from loss of control of subsidiaries	385,591	0
Tetra Drones [Member]
Disclosure of analysis of single amount of discontinued operations [line items]
Net liabilities before loss of control of subsidiaries	227,907
Receivables	120,500
Gain from loss of control of subsidiaries	$ 110,430	$ 0

DISCONTINUED OPERATIONS - LOS_4

DISCONTINUED OPERATIONS - LOSS OF CONTROL -Disclosure of net gain (loss) from discontinued operation (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
Discontinued Operations [Abstract]
Net Gain (Loss) from discontinued operations - loss of control	$ 995,142	$ (1,949,330)	$ (2,191,326)

DISCONTINUED OPERATIONS - LOS_5

DISCONTINUED OPERATIONS - LOSS OF CONTROL - Disclosure of results of operations of discontinued operations (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
OPERATING EXPENSES
General and administrative	$ 1,070,574	$ 826,439	$ 2,245,589
Business development	386,991	114,665	508,545
Total operating expenses	1,457,565	941,104	2,440,508
OTHER INCOME (EXPENSE)
Foreign exchange gain (loss)	(3,068)	(135)	(29,374)
Total other income (expense)	(146,505)	222,636	(29,374)
Loss from discontinued operations	995,142	(1,949,330)	(2,191,326)
PRT USA, PRT UK and Tetra Drones [Member]
Disclosure of analysis of single amount of discontinued operations [line items]
Sales	0	607,359	184,396
Cost of sales	0	(191,175)	(103,109)
Gross Profit	0	416,184	81,287
OPERATING EXPENSES
General and administrative	0	1,519,539	1,074,492
Business development	0	62,763	200,465
Research and development	0	233,264	985,006
Total operating expenses	0	1,815,566	2,259,963
OTHER INCOME (EXPENSE)
Impairment loss of demo equipment	0	(236,677)	0
Impairment of intangible asset	0	(330,650)	0
Other Income	0	5,042	0
Gain on debt forgiveness	0	11,532	0
Foreign exchange gain (loss)	0	805	(12,650)
Total other income (expense)	0	(549,948)	(12,650)
Loss from discontinued operations	$ 0	$ (1,949,330)	$ (2,191,326)

DISCONTINUED OPERATIONS - LOS_6

DISCONTINUED OPERATIONS - LOSS OF CONTROL - Disclosure of gain from loss of control of subsidiaries (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
Disclosure of analysis of single amount of discontinued operations [line items]
Net liabilities before loss of control of subsidiaries	$ 6,579,724
Foreign currency translation adjustments	(95,151)
Less: Receivables from subsidiaries	(5,489,431)
Gain from loss of control of subsidiaries	995,142	$ (1,949,330)	$ (2,191,326)
PRT USA [Member]
Disclosure of analysis of single amount of discontinued operations [line items]
Net liabilities before loss of control of subsidiaries	4,870,623
Foreign currency translation adjustments	(123,484)
Less: Receivables from subsidiaries	(4,248,018)
Gain from loss of control of subsidiaries	499,121	0
PRT UK [Member]
Disclosure of analysis of single amount of discontinued operations [line items]
Net liabilities before loss of control of subsidiaries	1,481,194
Foreign currency translation adjustments	25,310
Less: Receivables from subsidiaries	(1,120,913)
Gain from loss of control of subsidiaries	385,591	0
Tetra Drones [Member]
Disclosure of analysis of single amount of discontinued operations [line items]
Net liabilities before loss of control of subsidiaries	227,907
Foreign currency translation adjustments	3,023
Less: Receivables from subsidiaries	(120,500)
Gain from loss of control of subsidiaries	$ 110,430	$ 0

DISCONTINUED OPERATIONS - LOS_7

DISCONTINUED OPERATIONS - LOSS OF CONTROL - Disclosure of net assets and liabilities of discontinued operations (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021	Dec. 01, 2022
Current assets
Cash, cash equivalents, and restricted cash	$ 38,555	$ 13,127
Prepaid expenses	183,872	30,947
Accounts receivable	0	6,870
Inventories	0	2,175
Sales tax receivable	5,826	9,083
Non-current assets
Equipment	0	24,801
Right-of-use asset	0	61,198	$ 72,734
LIABILITIES
Accounts payable	77,126	1,063,863
Lease liability	0	66,403
Due to related parties	372,650	705,672
Deferred revenue	0	124,918
Loans payable	48,000	127,019
Carrying value of net liabilities immediately prior to loss of control of subsidiary	6,579,724
Receivable from subsidiary	(5,489,431)
Reclassification of foreign currency translation	(95,151)
Gain from loss of control of subsidiaries	995,142	(1,949,330)	$ (2,191,326)
PRT USA [Member]
Current assets
Cash, cash equivalents, and restricted cash				$ 9,700
Prepaid expenses				8,313
Accounts receivable				6,831
Inventories				2,163
Total current assets of discontinued operations				27,007
Non-current assets
Equipment				5,919
Right-of-use asset				38,189
Total non-current assets of discontinued operations				44,108
Assets of discontinued operations				71,115
LIABILITIES
Accounts payable				284,181
Lease liability				671,205
Due to related parties				4,608,071
Liabilities of discontinued operation				4,941,738
Carrying value of net liabilities immediately prior to loss of control of subsidiary	4,870,623
Receivable from subsidiary	(4,248,018)
Reclassification of foreign currency translation	(123,484)
Gain from loss of control of subsidiaries	499,121	0
PRT UK [Member]
Current assets
Cash, cash equivalents, and restricted cash				3,852
Prepaid expenses				8,983
Total current assets of discontinued operations				12,835
Non-current assets
Equipment				9,171
Right-of-use asset				24,686
Total non-current assets of discontinued operations				33,857
Assets of discontinued operations				46,692
LIABILITIES
Accounts payable				455,062
Lease liability				26,456
Due to related parties				919,436
Deferred revenue				124,918
Liabilities of discontinued operation				1,527,886
Carrying value of net liabilities immediately prior to loss of control of subsidiary	1,481,194
Receivable from subsidiary	(1,120,913)
Reclassification of foreign currency translation	25,310
Gain from loss of control of subsidiaries	385,591	0
Tetra Drones [Member]
Current assets
Sales tax receivable				435
Total current assets of discontinued operations				435
Non-current assets
Equipment				9,982
Total non-current assets of discontinued operations				9,982
Assets of discontinued operations				10,417
LIABILITIES
Bank overdrafts				16,294
Accounts payable				12,043
Due to related parties				209,738
Loans payable				249
Liabilities of discontinued operation				$ 238,324
Carrying value of net liabilities immediately prior to loss of control of subsidiary	227,907
Receivable from subsidiary	(120,500)
Reclassification of foreign currency translation	3,023
Gain from loss of control of subsidiaries	$ 110,430	$ 0

PREPAID EXPENSES - Disclosure o

PREPAID EXPENSES - Disclosure of prepaid expenses (Details) - CAD ($)	Nov. 30, 2023	Nov. 30, 2022
Prepaid Expenses [Line Items]
Prepaid expenses	$ 183,872	$ 30,947
Advertising and promotions [Member]
Prepaid Expenses [Line Items]
Prepaid expenses	0	113
Investor relations [Member]
Prepaid Expenses [Line Items]
Prepaid expenses	85,510	0
Professional fees [Member]
Prepaid Expenses [Line Items]
Prepaid expenses	7,469	0
Consulting fees [Member]
Prepaid Expenses [Line Items]
Prepaid expenses	80,000	0
Rent [Member]
Prepaid Expenses [Line Items]
Prepaid expenses	0	8,247
Transfer agent and filing fees [Member]
Prepaid Expenses [Line Items]
Prepaid expenses	7,143	13,748
Insurance [Member]
Prepaid Expenses [Line Items]
Prepaid expenses	$ 3,750	$ 8,839

EQUIPMENT (Narrative) (Details)

EQUIPMENT (Narrative) (Details)	Nov. 30, 2023 CAD ($)
Property, plant and equipment [abstract]
Property, plant and equipment derecognized in connection with loss of control of subsidiaries	$ 24,801

EQUIPMENT - Disclosure of prope

EQUIPMENT - Disclosure of property, plant and equipment (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Disclosure of detailed information about property, plant and equipment [line items]
Beginning balance	$ 24,801
Ending balance	0	$ 24,801
Cost [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Beginning balance	289,041	302,886
Disposal	(292,320)	(16,243)
Foreign currency translation adjustment	3,279	2,398
Ending balance	0	289,041
Accumulated Depreciation [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Beginning balance	(264,240)	(8,698)
Amortization	2,326	17,140
Disposal	(269,503)	(5,375)
Impairment		236,677
Foreign currency translation adjustment	2,937	7,100
Ending balance	0	(264,240)
Computer [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Beginning balance	11,437
Ending balance	0	11,437
Computer [Member] | Cost [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Beginning balance	23,031	24,028
Disposal	(23,392)	0
Foreign currency translation adjustment	361	(997)
Ending balance	0	23,031
Computer [Member] | Accumulated Depreciation [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Beginning balance	(11,594)	(1,716)
Amortization	1,593	9,236
Disposal	(13,367)	0
Impairment		0
Foreign currency translation adjustment	180	642
Ending balance	0	(11,594)
Furniture [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Beginning balance	11,004
Ending balance	0	11,004
Furniture [Member] | Cost [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Beginning balance	19,461	19,271
Disposal	(19,667)	0
Foreign currency translation adjustment	206	190
Ending balance	0	19,461
Furniture [Member] | Accumulated Depreciation [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Beginning balance	(8,457)	(5,473)
Amortization	554	2,688
Disposal	(9,092)	0
Impairment		0
Foreign currency translation adjustment	81	296
Ending balance	0	(8,457)
Vehicles [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Beginning balance	0
Ending balance	0	0
Vehicles [Member] | Cost [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Beginning balance	0	16,014
Disposal	0	(16,243)
Foreign currency translation adjustment	0	229
Ending balance	0	0
Vehicles [Member] | Accumulated Depreciation [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Beginning balance	0	(1,218)
Amortization	0	4,210
Disposal	0	(5,375)
Impairment		0
Foreign currency translation adjustment	0	(53)
Ending balance	0	0
Leasehold Improvement [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Beginning balance	2,360
Ending balance	0	2,360
Leasehold Improvement [Member] | Cost [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Beginning balance	3,644	3,826
Disposal	(3,703)	0
Foreign currency translation adjustment	59	(182)
Ending balance	0	3,644
Leasehold Improvement [Member] | Accumulated Depreciation [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Beginning balance	(1,284)	(291)
Amortization	179	1,006
Disposal	(1,486)	0
Impairment		0
Foreign currency translation adjustment	23	(13)
Ending balance	0	(1,284)
Demo Equipment [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Beginning balance	0
Ending balance	0	0
Demo Equipment [Member] | Cost [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Beginning balance	242,905	239,747
Disposal	(245,558)	0
Foreign currency translation adjustment	2,653	3,158
Ending balance	0	242,905
Demo Equipment [Member] | Accumulated Depreciation [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Beginning balance	(242,905)	0
Amortization	0	0
Disposal	(245,558)	0
Impairment		236,677
Foreign currency translation adjustment	2,653	6,228
Ending balance	$ 0	$ (242,905)

LONG-TERM RECEIVABLE (Narrative

LONG-TERM RECEIVABLE (Narrative) (Details)		1 Months Ended					12 Months Ended
	Aug. 11, 2023 CAD ($)	Nov. 30, 2023 CAD ($)	Nov. 24, 2023 CAD ($)	Sep. 28, 2023 CAD ($)	Jul. 25, 2023 CAD ($)	May 29, 2023 CAD ($)	Nov. 30, 2023 CAD ($)	Nov. 30, 2022 CAD ($)	Nov. 30, 2021 CAD ($)	Nov. 30, 2023 GBP (£)	Nov. 24, 2023 GBP (£)	Sep. 28, 2023 GBP (£)	Aug. 11, 2023 GBP (£)	Jul. 25, 2023 GBP (£)	May 29, 2023 GBP (£)
Disclosure Of Long Term Receivable [Line Items]
Loans and receivables	$ 26,017	$ 209,702	$ 17,749	$ 17,093	$ 60,151	$ 84,929	$ 209,702			£ 122,203	£ 10,000	£ 10,000	£ 15,000	£ 35,000	£ 50,000
Interest rate on long term receivables	5%		5%	5%	5%	5%					5%	5%	5%	5%	5%
Description of option to convert to equity	Company has the option to convert the full amount to 1.5% of the diluted share capital of the third party.		Company has the option to convert the full amount to 1% of the diluted share capital of the third party.	Company has the option to convert the full amount to 1% of the diluted share capital of the third party.	Company has the option to convert the full amount to 3.5% of the diluted share capital of the third party.	Company has the option to convert the full amount to 5% of the diluted share capital of the third party.
Interest receivable		3,765					3,765			£ 2,203
Impairment loss on financial assets		$ 209,702					$ 209,702	$ 0	$ 0

ACCOUNTS PAYABLE - Disclosure o

ACCOUNTS PAYABLE - Disclosure of accounts payable (Details) - CAD ($)	Nov. 30, 2023	Nov. 30, 2022
Trade And Other Payable [Line Items]
Accounts payable	$ 77,126	$ 1,063,863
Professional fees [Member]
Trade And Other Payable [Line Items]
Accounts payable	22,116	382,805
Funds to be returned to investors [Member]
Trade And Other Payable [Line Items]
Accounts payable	43,046	43,046
Advertising costs [Member]
Trade And Other Payable [Line Items]
Accounts payable	2,520	34,705
Payroll [Member]
Trade And Other Payable [Line Items]
Accounts payable	0	268,610
Development costs [Member]
Trade And Other Payable [Line Items]
Accounts payable	0	168,925
Bank overdraft [Member]
Trade And Other Payable [Line Items]
Accounts payable	0	16,036
VAT Payable [Member]
Trade And Other Payable [Line Items]
Accounts payable	0	61,262
Purchases [Member]
Trade And Other Payable [Line Items]
Accounts payable	0	2,121
Rent [Member]
Trade And Other Payable [Line Items]
Accounts payable	0	1,822
Others [Member]
Trade And Other Payable [Line Items]
Accounts payable	$ 9,444	$ 84,531

DEFERRED REVENUE (Narrative) (D

DEFERRED REVENUE (Narrative) (Details) - CAD ($)	Nov. 30, 2023	Nov. 30, 2022
Disclosure of disaggregation of revenue from contracts with customers [abstract]
Deferred revenue	$ 0	$ 124,918

RELATED PARTY TRANSACTIONS AN_3

RELATED PARTY TRANSACTIONS AND BALANCES (Narrative) (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
Disclosure of transactions between related parties [line items]
Due to directors and officers	$ 372,650	$ 705,672
Office and general expenses	1,070,574	826,439	$ 2,245,589
Gain on debt forgiveness	$ 62,500	$ 222,771	0
Directors and officers [Member]
Disclosure of transactions between related parties [line items]
Number of options held	1,850,000	1,750,000
Company controlled by a director [Member]
Disclosure of transactions between related parties [line items]
Due to directors and officers	$ 5,000	$ 0
Accounting fees	$ 63,844	$ 0	$ 36,202
Number of options held	800,000	750,000	825,000
Rent	$ 0	$ 0	$ 5,000
CEO [Member]
Disclosure of transactions between related parties [line items]
Current borrowings	$ 6,000
Borrowings, interest rate	10%
Number of options held	800,000	0	0
Travel	$ 3,467	$ 0	$ 0
Office and general expenses	$ 3,677	0	$ 0
Directors and former Officers [Member]
Disclosure of transactions between related parties [line items]
Stock options cancelled	1,650,000
Former CEO [Member]
Disclosure of transactions between related parties [line items]
Due to directors and officers	$ 0	$ 250,179
Number of options held	0	600,000	600,000
Salaries	$ 54,100	$ 330,337	$ 313,626
Company controlled by President and CEO [Member]
Disclosure of transactions between related parties [line items]
Due to directors and officers	6,077	78,750
Gain on debt forgiveness	$ 62,500	$ 0	$ 0

RELATED PARTY TRANSACTIONS AN_4

RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of amounts due to directors and officers (Details) - CAD ($)	Nov. 30, 2023	Nov. 30, 2022
Disclosure of transactions between related parties [line items]
Due to directors and officers	$ 372,650	$ 705,672
Company controlled by the President and CEO [Member]
Disclosure of transactions between related parties [line items]
Due to directors and officers	6,077	78,750
Director and Chairman [Member]
Disclosure of transactions between related parties [line items]
Due to directors and officers	0	1,731
Former CFO of the Company [Member]
Disclosure of transactions between related parties [line items]
Due to directors and officers	0	67,540
Former interim CEO of the Company [Member]
Disclosure of transactions between related parties [line items]
Due to directors and officers	0	250,179
Former CEO and Director [Member]
Disclosure of transactions between related parties [line items]
Due to directors and officers	361,573	307,472
Company controlled by a director [Member]
Disclosure of transactions between related parties [line items]
Due to directors and officers	5,000	0
Related parties [Member]
Disclosure of transactions between related parties [line items]
Due to directors and officers	$ 372,650	$ 705,672

RELATED PARTY TRANSACTIONS AN_5

RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of transactions between related parties (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
Disclosure of transactions between related parties [line items]
Stock-based compensation	$ 37,405	$ 0	$ 1,144,342
Related parties [Member]
Disclosure of transactions between related parties [line items]
Management fees	92,127	0	55,000
Consulting fees	47,500	135,000	307,734
Accounting fees	63,844	0	36,202
Professional fees	10,429	0	0
Stock-based compensation	57,425	0	410,132
Salaries and benefits	54,100	330,337	313,626
Others	7,144	0	5,000
Transactions with related parties	$ 332,569	$ 465,337	$ 1,127,694

RELATED PARTY TRANSACTIONS AN_6

RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of management fees (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
Company controlled by the President and CEO [Member]
Disclosure of transactions between related parties [line items]
Management fees	$ 35,000	$ 0	$ 0
CFO [Member]
Disclosure of transactions between related parties [line items]
Management fees	30,000	0
Former Interim CEO [Member]
Disclosure of transactions between related parties [line items]
Management fees	27,127	0	0
Former CFO of the Company [Member]
Disclosure of transactions between related parties [line items]
Management fees	0	0	55,000
Related parties [Member]
Disclosure of transactions between related parties [line items]
Management fees	$ 92,127	$ 0	$ 55,000

RELATED PARTY TRANSACTIONS AN_7

RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of consulting fees (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
Company controlled by the President and CEO [Member]
Disclosure of transactions between related parties [line items]
Consulting fees	$ 47,500	$ 75,000	$ 0
Company controlled by the Former Corporate Secretary [Member]
Disclosure of transactions between related parties [line items]
Consulting fees	0	60,000	0
Director [Member]
Disclosure of transactions between related parties [line items]
Consulting fees	0	0	307,734
Related parties [Member]
Disclosure of transactions between related parties [line items]
Consulting fees	$ 47,500	$ 135,000	$ 307,734

RELATED PARTY TRANSACTIONS AN_8

RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of professional fees (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
CFO and Former Corporate Secretary [Member]
Disclosure of transactions between related parties [line items]
Professional fees	$ 1,000	$ 0	$ 0
Company controlled by the Corporate Secretary [Member]
Disclosure of transactions between related parties [line items]
Professional fees	9,429	0	0
Related parties [Member]
Disclosure of transactions between related parties [line items]
Professional fees	$ 10,429	$ 0	$ 0

RELATED PARTY TRANSACTIONS AN_9

RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of stock options held by Directors and officers (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
Disclosure of transactions between related parties [line items]
Expense for the year (vested)	$ 37,405	$ 0	$ 1,144,342
CEO [Member]
Disclosure of transactions between related parties [line items]
Number of options held	800,000	0	0
Expense for the year (vested)	$ 24,834	$ 0	$ 0
CFO [Member]
Disclosure of transactions between related parties [line items]
Number of options held	200,000	0	0
Expense for the year (vested)	$ 6,208	$ 0	$ 0
Corporate Secretary [Member]
Disclosure of transactions between related parties [line items]
Number of options held	50,000	0	0
Expense for the year (vested)	$ 1,552	$ 0	$ 0
Former CEO [Member]
Disclosure of transactions between related parties [line items]
Number of options held	0	600,000	600,000
Expense for the year (vested)	$ 0	$ 0	$ 133,275
Former CFO [Member]
Disclosure of transactions between related parties [line items]
Number of options held	0	150,000	150,000
Expense for the year (vested)	$ 0	$ 0	$ 33,319
Former Corporate Secretary [Member]
Disclosure of transactions between related parties [line items]
Number of options held	0	150,000	150,000
Expense for the year (vested)	$ 0	$ 0	$ 33,319
Directors [Member]
Disclosure of transactions between related parties [line items]
Number of options held	800,000	750,000	825,000
Expense for the year (vested)	$ 24,868	$ 0	$ 210,219
Related parties [Member]
Disclosure of transactions between related parties [line items]
Number of options held	1,850,000	1,650,000	1,725,000
Expense for the year (vested)	$ 57,425	$ 0	$ 410,132

LOANS PAYABLE (Narrative) (Deta

LOANS PAYABLE (Narrative) (Details)	1 Months Ended		12 Months Ended
	Oct. 25, 2022 CAD ($)	Oct. 25, 2022 GBP (£)	Nov. 30, 2023 CAD ($)	Nov. 30, 2022 CAD ($)	Nov. 30, 2022 GBP (£)
Loans Payable [Line Items]
Borrowing costs recognised as expense			$ 18,000	$ 18,000
Outstanding loan			48,000	127,019
Tetra [Member]
Loans Payable [Line Items]
Latter of outstanding loan				21,461	£ 13,253
Remaining acquisition related cost	$ 222,771	£ 140,000
Third Party [Member]
Loans Payable [Line Items]
Current borrowings			81,238	127,019
Borrowing costs recognised as expense			75,000	75,000
Interest payable			$ 6,238	$ 4,019
Borrowings, interest rate			12%	12%	12%
Third Party [Member] | Loan Agreements [Member]
Loans Payable [Line Items]
Interest payable			$ 6,000
Borrowings, interest rate			10%
Outstanding loan			$ 4,000
Another Third Party [Member]
Loans Payable [Line Items]
Borrowing costs recognised as expense			$ 30,000
Borrowings, interest rate			60%	60%	60%

SHARE CAPITAL (Narrative) (Deta

SHARE CAPITAL (Narrative) (Details)				1 Months Ended										12 Months Ended
	Aug. 09, 2021 CAD ($) Year share $ / shares shares	Jun. 10, 2021 CAD ($) Year share $ / shares	Nov. 12, 2014	Oct. 19, 2023 CAD ($) Year share $ / shares	Aug. 18, 2023 CAD ($) Year share $ / shares	Jul. 24, 2023 CAD ($) Year share $ / shares shares	May 30, 2023 CAD ($) shares	Mar. 30, 2023 CAD ($) Year share $ / shares shares	Mar. 27, 2023 CAD ($) Year share $ / shares shares	Dec. 31, 2021 CAD ($) shares	Jan. 29, 2021 CAD ($) Year share $ / shares shares	Jan. 21, 2021 CAD ($) Year share $ / shares	Apr. 25, 2018	Nov. 30, 2023 CAD ($) share $ / shares shares	Nov. 30, 2022 CAD ($) share $ / shares shares	Nov. 30, 2021 CAD ($) share $ / shares shares	Nov. 30, 2020 shares
Disclosure of classes of share capital [line items]
Proceeds from warrants exercised | $																$ 1,332,727
Number of units issued | shares	5,750,000										3,180,000
Price per unit issued	0.4										0.2
Proceeds from units issued | $	$ 2,300,000										$ 636,000
Number of warrants granted | share														47,425,700
Exercise price of warrants granted														$ 0.1
Number of share options exercised | share																425,000
Proceeds from exercise of options | $																$ 222,500
Share issue related cost | $														$ 233,403
Percentage of common shares reserved for issuance			10%
Number of stock options granted | share														3,450,000
Exercise price of stock options granted														$ 0.04
Remaining contractual life of stock option														3 years 3 months 3 days
Number of options Expired | share															75,000
Weighted average exercise price, Expired															$ 0.5
Number of options cancelled | share														3,900,000	125,000
Weighted average exercise price, cancelled														$ 0.66	$ 0.5
Stock-based compensation recognized in profit or loss | $														$ 37,405	$ 0	1,144,342
Value of common shares issued as compensation for consulting fees | $														$ 169,000	$ 17,189	$ 307,734
Bottom of range [Member]
Disclosure of classes of share capital [line items]
Weighted average exercise price, exercised																$ 0.5
Top of range [Member]
Disclosure of classes of share capital [line items]
Weighted average exercise price, exercised																$ 0.6
Share capital [Member]
Disclosure of classes of share capital [line items]
Number of shares issued and outstanding | shares														105,504,461	59,317,461	59,239,336	42,762,264
Proceeds from warrants exercised | $																$ 1,332,727
Share issue related cost | $														$ 233,403
Common shares issued as compensation for consulting fees | shares														2,600,000	78,125	656,250
Value of common shares issued as compensation for consulting fees | $														$ 169,000	$ 17,189	$ 307,734
Directors, Officers, employees and consultants [Member]
Disclosure of classes of share capital [line items]
Number of stock options granted | share					2,450,000							1,550,000
Exercise price of stock options granted					$ 0.05							$ 0.75
Remaining contractual life of stock option					3 years							5 years
Stock price					$ 0.03104							$ 0.75
Volatility					96%							100%
Risk-free rate					4.51%							0.43%
Dividend yield					0%							0%
Expected life | Year					3							5
Fair value of stock option | $					$ 76,048							$ 1,022,995
Consultant [Member]
Disclosure of classes of share capital [line items]
Number of stock options granted | share		150,000		1,000,000	650,000
Exercise price of stock options granted		$ 0.5		$ 0.05
Remaining contractual life of stock option		5 years		3 years
Stock price		$ 0.485		$ 0.02351
Volatility		100%		91%
Risk-free rate		0.82%		4.91%
Dividend yield		0%		0%
Expected life | Year		5		5
Fair value of stock option | $		$ 53,677		$ 23,540
Director [Member]
Disclosure of classes of share capital [line items]
Number of shares issued for services | shares										78,125
Value of shares issued for services | $										$ 17,189
Stock-based compensation recognized in profit or loss | $														$ 24,868	$ 0	$ 210,219
Common shares issued as compensation for consulting fees | shares																656,250
Value of common shares issued as compensation for consulting fees | $																$ 307,734
Arm's length party [Member]
Disclosure of classes of share capital [line items]
Number of shares issued for services | shares							2,600,000
Value of shares issued for services | $							$ 169,000
Directors And Officers [Member]
Disclosure of classes of share capital [line items]
Number of stock options granted | share					1,800,000
Private placements [Member]
Disclosure of classes of share capital [line items]
Number of share purchase warrants exercised | shares																4,240
Weighted average exercise price of warrants exercised																$ 0.25
Number of warrants granted | share	325,750										222,400
Exercise price of warrants granted	$ 0.5										$ 0.5
Stock price	$ 0.35										$ 0.52
Volatility	100%										100%
Risk-free rate	0.88%										0.43%
Dividend yield	0%										0%
Expected life | Year	5					5					5
Fair value of stock option | $	$ 79,032										$ 95,395
Finder's fees [Member]
Disclosure of classes of share capital [line items]
Exercise price of warrants granted	$ 0.5										$ 0.25
Warrants granted, exercisable period	5 years										5 years
Shares issued for finder's fees, value | $	$ 63,700										$ 10,480
Shares issued for finder's fees, shares | shares	166,250										170,000
Fair value of finders units issued | $	$ 66,500										$ 34,000
Non-brokered private placement financing [Member]
Disclosure of classes of share capital [line items]
Number of share purchase warrants exercised | shares																30,000
Weighted average exercise price of warrants exercised																$ 0.25
Number of units issued | shares						9,907,000		26,480,000	7,200,000
Price per unit issued						0.06		0.05	0.05
Proceeds from units issued | $						$ 594,420		$ 1,324,000	$ 360,000
Number of warrants granted | share											3,350,000
Exercise price of warrants granted						$ 0.1		$ 0.1	$ 0.1		$ 0.25
Warrants granted, exercisable period						5 years		3 years	3 years
Exercise price of finders b warrants granted								$ 0.1	$ 0.1		0.1
Finders b warrants granted exercisable period								3 years	3 years				5 years
Payments for finders fees | $						$ 59,442		$ 95,900	$ 46,500
Payments for legal fees | $						$ 8,082		$ 17,500	$ 6,000
Payments for finders' b-warrants | shares						990,700		2,648,000	200,000
Share purchase warrant [Member]
Disclosure of classes of share capital [line items]
Number of share purchase warrants exercised | shares															561,081	6,129,573
Weighted average exercise price of warrants exercised															$ 0.2
Proceeds from warrants exercised | $																$ 1,332,727
Number of warrants granted | share	5,916,250					9,907,000		26,480,000	7,200,000
Exercise price of warrants granted	$ 0.5					$ 0.1		$ 0.1	$ 0.1		$ 0.25
Warrants granted, exercisable period	5 years										5 years
Discription of residual approach						The Company has allocated 100% proceeds to common share and $Nil to share purchase warrants by adopting the residual approach.		The Company has allocated 100% proceeds to common share and $Nil to share purchase warrants by adopting the residual approach.	The Company has allocated 100% proceeds to common share and $Nil to share purchase warrants by adopting the residual approach.
Share purchase warrant [Member] | Bottom of range [Member]
Disclosure of classes of share capital [line items]
Weighted average exercise price of warrants exercised																$ 0.2
Share purchase warrant [Member] | Top of range [Member]
Disclosure of classes of share capital [line items]
Weighted average exercise price of warrants exercised																$ 0.5
Broker warrants [Member]
Disclosure of classes of share capital [line items]
Exercise price of warrants granted	$ 0.5										$ 0.25
Warrants granted, exercisable period	5 years										5 years
Shares issued for finder's fees, shares | shares	325,750										222,400
Finders agreement warrants to agent [Member]
Disclosure of classes of share capital [line items]
Number of warrants granted | share						990,700
Warrants granted, estimated fair value | $						$ 45,364
Exercise price of warrants granted						$ 0.1
Warrants granted, exercisable period						5 years
Forfeiture rate						0%
Volatility						100%
Risk-free rate						3.90%
Dividend yield						0%
Expected life | Year						5
Agency agreement warrants [Member]
Disclosure of classes of share capital [line items]
Number of warrants granted | share								2,648,000	200,000
Warrants granted, estimated fair value | $								$ 94,537	$ 9,439
Exercise price of warrants granted								$ 0.1	$ 0.1
Warrants granted, exercisable period								3 years	3 years
Forfeiture rate								0%	0%
Volatility								100%	100%
Risk-free rate								3.53%	3.40%
Dividend yield								0%	0%
Expected life | Year								3	3
First tranche [Member]
Disclosure of classes of share capital [line items]
Number of options cancelled | share														2,200,000
Weighted average exercise price, cancelled														$ 0.6
Second tranche [Member]
Disclosure of classes of share capital [line items]
Number of options cancelled | share														1,550,000
Weighted average exercise price, cancelled														$ 0.75
Third tranche [Member]
Disclosure of classes of share capital [line items]
Number of options cancelled | share														150,000
Weighted average exercise price, cancelled														$ 0.5

SHARE CAPITAL - Disclosure of n

SHARE CAPITAL - Disclosure of number and weighted average exercise prices of share options (Details)	12 Months Ended
	Nov. 30, 2023 share $ / shares	Nov. 30, 2022 share $ / shares
Disclosure of classes of share capital [abstract]
Number of options outstanding, beginning balance | share	4,025,000	4,225,000
Weighted average exercise price, beginning balance | $ / shares	$ 0.66	$ 0.64
Number of options Expired | share		(75,000)
Weighted average exercise price, Expired | $ / shares		$ 0.5
Number of options cancelled | share	(3,900,000)	(125,000)
Weighted average exercise price, cancelled | $ / shares	$ 0.66	$ 0.5
Number of stock options granted | share	3,450,000
Exercise price of stock options granted | $ / shares	$ 0.04
Number of options outstanding, ending balance | share	3,575,000	4,025,000
Weighted average exercise price, ending balance | $ / shares	$ 0.06	$ 0.66

SHARE CAPITAL - Disclosure of_2

SHARE CAPITAL - Disclosure of number and weighted average remaining contractual life of outstanding share options (Details)	12 Months Ended
	Nov. 30, 2023 share $ / shares	Nov. 30, 2022 share	Nov. 30, 2021 share
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Numbers of options outstanding	3,575,000	4,025,000	4,225,000
Numbers of options exercisable	3,482,917
Weighted average remaining contractual life (year)	3 years 3 months 3 days
Weighted average exercise price | $ / shares	$ 0.06
November 28, 2024 [Member] | Exercise Price 0.50 [Member]
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Exercise Price | $ / shares	$ 0.5
Numbers of options outstanding	125,000
Numbers of options exercisable	125,000
Weighted average remaining contractual life (year)	10 days
Weighted average exercise price | $ / shares	$ 0.02
August 18, 2026 [Member] | Exercise Price 0.05 [Member]
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Exercise Price | $ / shares	$ 0.05
Numbers of options outstanding	2,450,000
Numbers of options exercisable	2,357,917
Weighted average remaining contractual life (year)	1 year 10 months 9 days
Weighted average exercise price | $ / shares	$ 0.03
October 19, 2028 [Member] | Exercise Price 0.05 [Member]
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Exercise Price | $ / shares	$ 0.05
Numbers of options outstanding	1,000,000
Numbers of options exercisable	1,000,000
Weighted average remaining contractual life (year)	1 year 4 months 13 days
Weighted average exercise price | $ / shares	$ 0.01

SHARE CAPITAL - Disclosure of s

SHARE CAPITAL - Disclosure of share purchase warrant transactions (Details)	12 Months Ended
	Nov. 30, 2023 share $ / shares	Nov. 30, 2022 share $ / shares
Disclosure of classes of share capital [abstract]
Warrants outstanding, beginning balance | share	9,430,160	9,991,241
Weighted average exercise price, beginning balance | $ / shares	$ 0.42	$ 0.42
Warrants expired | share		(561,081)
Weighted average exercise price of warrants expired | $ / shares		$ 0.2
Warrants granted | share	47,425,700
Weighted average exercise price of warrants granted | $ / shares	$ 0.1
Warrants outstanding, ending balance | share	56,855,860	9,430,160
Weighted average exercise price, ending balance | $ / shares	$ 0.14	$ 0.42

SHARE CAPITAL - Disclosure of_3

SHARE CAPITAL - Disclosure of number of share purchase warrants outstanding (Details)	12 Months Ended
	Nov. 30, 2023 share $ / shares	Nov. 30, 2022 share $ / shares	Nov. 30, 2021 share $ / shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of Warrants outstanding and exercisable | share	56,855,860	9,430,160	9,991,241
Weighted average remaining contractual life (year)	2 years 9 months 18 days
Weighted average exercise price	$ 0.14	$ 0.42	$ 0.42
January 29, 2026 [Member]
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Exercise Price	$ 0.25
Number of Warrants outstanding and exercisable | share	3,188,160
Weighted average remaining contractual life (year)	1 month 13 days
Weighted average exercise price	$ 0.01
March 27, 2026 [Member]
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Exercise Price	$ 0.1
Number of Warrants outstanding and exercisable | share	7,400,000
Weighted average remaining contractual life (year)	3 months 18 days
Weighted average exercise price	$ 0.01
March 30, 2026 [Member]
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Exercise Price	$ 0.1
Number of Warrants outstanding and exercisable | share	29,128,000
Weighted average remaining contractual life (year)	1 year 2 months 8 days
Weighted average exercise price	$ 0.05
August 9, 2026 [Member]
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Exercise Price	$ 0.5
Number of Warrants outstanding and exercisable | share	6,242,000
Weighted average remaining contractual life (year)	3 months 18 days
Weighted average exercise price	$ 0.05
July 24, 2028 [Member]
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Exercise Price	$ 0.1
Number of Warrants outstanding and exercisable | share	10,897,700
Weighted average remaining contractual life (year)	10 months 20 days
Weighted average exercise price	$ 0.02

FINANCIAL RISK MANAGEMENT (Narr

FINANCIAL RISK MANAGEMENT (Narrative) (Details) - Foreign Currency Risk [Member] - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
Disclosure of nature and extent of risks arising from financial instruments [line items]
Potential fluctuations in functional currency exchange rate	10%
Comprehensive loss due to fluctuations in US dollar against the Canadian dollar	$ 20,587	$ 7,464	$ 26,633

SUPPLEMENTAL CASH FLOW INFORM_3

SUPPLEMENTAL CASH FLOW INFORMATION - Disclosure of supplemental cash flow information (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
Non-cash financing activities
Fair value of options granted and vested	$ 99,588	$ 17,189	$ 1,144,342
Fair value of options exercised	0	0	158,106
Fair value of warrants granted	149,340	0	174,427
Fair value of warrants exercised	0	0	36,859
Shares issued for finders	0	0	100,500
Shares issued as compensation	169,000	17,189	307,734
Cash payments for:
Interest	6,238	0	0
Taxes	$ 0	$ 0	$ 0

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Narrative) (Details)	12 Months Ended
	Nov. 30, 2023 CAD ($)
Commitments And Contingencies [Abstract]
Key management compensation	$ 10,000

RIGHT-OF-USE ASSETS AND LEASE_3

RIGHT-OF-USE ASSETS AND LEASE LIABILITY (Narrative) (Details)		1 Months Ended
	Sep. 09, 2021 GBP (£)	Nov. 30, 2018	Nov. 30, 2023 CAD ($)	Nov. 30, 2023 USD ($)	Nov. 30, 2022 CAD ($)	Nov. 30, 2022 USD ($)	Nov. 30, 2021 CAD ($)	Nov. 30, 2021 USD ($)	Nov. 30, 2020 CAD ($)	Nov. 30, 2020 USD ($)
PRT USA [Member]
Disclosure of maturity analysis of operating lease payments [line items]
Term of lease		2 years
Monthly lease payment, next twelve months									$ 3,726	$ 3,005
Monthly lease payment, year two							$ 3,838	$ 3,095
Monthly lease payment, year three					$ 3,953	$ 3,188
Monthly lease payment, year four			$ 4,072	$ 3,284
PRT UK [Member]
Disclosure of maturity analysis of operating lease payments [line items]
Annual lease fee	£ 12,000
Monthly lease payment	£ 1,000
Annual interest rate of lease	4%

RIGHT-OF-USE ASSETS AND LEASE_4

RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of continuity of the cost and accumulated amortization of right-of-use assets (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Right Of Use Assets And Lease Liability [Abstract]
Opening balance	$ 61,198	$ 72,734
Additions		38,027
Amortization expense		(50,571)
Cumulative translation adjustment	1,677	1,008
Disposal of net liabilities due to loss of control	(62,875)
Closing balance	$ 0	$ 61,198

RIGHT-OF-USE ASSETS AND LEASE_5

RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of continuity of lease liability (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Right Of Use Assets And Lease Liability [Abstract]
Opening balance	$ 75,797	$ 86,346
Additions		38,027
Lease payments		(72,727)
Interest on lease liability		18,877
Cumulative translation adjustment	145	5,274
Disposal of net liabilities due to loss of control	(75,942)
Closing balance	$ 0	$ 75,797

RIGHT-OF-USE ASSETS AND LEASE_6

RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of minimum lease payments for the lease liabilities (Details) - CAD ($)	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
Disclosure of maturity analysis of operating lease payments [line items]
Minimum lease payments for lease liabilities	$ 0	$ 82,380
Less: Interest expense on lease liabilities	0	(6,583)
Total present value of minimum lease payments	0	75,797	$ 86,346
2023 [Member]
Disclosure of maturity analysis of operating lease payments [line items]
Minimum lease payments for lease liabilities	0	72,664
2024 [Member]
Disclosure of maturity analysis of operating lease payments [line items]
Minimum lease payments for lease liabilities	$ 0	$ 9,716

BREAKDOWN OF EXPENSES (Narrativ

BREAKDOWN OF EXPENSES (Narrative) (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
Disclosure of attribution of expenses by nature to their function [abstract]
Business development expenses	$ 386,991	$ 114,665	$ 508,545

BREAKDOWN OF EXPENSES - Disclos

BREAKDOWN OF EXPENSES - Disclosure of breakdown of expenses (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
Disclosure of attribution of expenses by nature to their function [line items]
Stock-based compensation	$ 37,405	$ 0	$ 1,144,342
Total	1,070,574	826,439	2,245,589
General and Administrative Expenses [Member]
Disclosure of attribution of expenses by nature to their function [line items]
Accounting and audit fees	92,723	192,403	73,202
Consulting fees	136,475	138,523	328,805
Investor relations	261,908	0	0
General office expenses	20,209	31,160	13,033
Insurance	11,180	16,065	11,401
Legal fees	224,140	51,603	152,144
Management fees	92,127	0	118,000
Rent	6,000	6,963	10,726
Salaries and benefits	54,100	330,337	313,626
Stock-based compensation	99,588	0	1,144,342
Transfer agent and filing fees	63,912	59,385	80,310
Travel	8,212
Total	$ 1,070,574	$ 826,439	$ 2,245,589

INCOME TAXES (Narrative) (Detai

INCOME TAXES (Narrative) (Details) - CAD ($)	Nov. 30, 2023	Nov. 30, 2022
Income taxes paid (refund) [abstract]
Non-capital losses carryforwards	$ 6,464,410	$ 5,061,190

INCOME TAXES - Disclosure of de

INCOME TAXES - Disclosure of detailed information about effective income tax expense (recovery) (Details) - CAD ($)	12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021
Disclosure Of Income Taxes [Line Items]
Net loss before tax and comprehensive loss	$ (608,928)	$ (2,667,798)	$ (4,974,834)
Statutory tax rate	27%	27%	27%
Expected income tax (recovery)	$ (164,000)	$ (720,000)	$ (1,343,000)
Permanent differences	(185,000)	617,000	985,000
Non-deductible items and others	1,848,000	1,436,000	1,331,000
Share issuance costs	63,000	0	0
Change in deferred tax assets not recognized	(1,562,000)	(1,333,000)	(973,000)
Income tax expense (recovery)	$ 0	$ 0	$ 0

INCOME TAXES - Disclosure of te

INCOME TAXES - Disclosure of temporary difference, unused tax losses and unused tax credits (Details) - CAD ($)	Nov. 30, 2023	Nov. 30, 2022
Income taxes paid (refund) [abstract]
Non-capital loss	$ 1,745,000	$ 1,367,000
Capital losses	21,000	21,000
Share issuance costs	82,000	48,000
Unrecognized deferred tax assets	(1,848,000)	(1,436,000)
Net deferred tax assets	$ 0	$ 0

INCOME TAXES - Disclosure of no

INCOME TAXES - Disclosure of non-capital loss carryforwards (Details) - CAD ($)	Nov. 30, 2023	Nov. 30, 2022
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Non-capital losses carryforwards	$ 6,464,410	$ 5,061,190
2038 [Member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Non-capital losses carryforwards	675,203
2039 [Member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Non-capital losses carryforwards	941,464
2040 [Member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Non-capital losses carryforwards	1,561,728
2041 [Member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Non-capital losses carryforwards	1,412,265
2042 [Member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Non-capital losses carryforwards	470,530
2043 [Member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Non-capital losses carryforwards	$ 1,403,221

SUBSEQUENT EVENTS (Narrative) (

SUBSEQUENT EVENTS (Narrative) (Details)					1 Months Ended						12 Months Ended
	Mar. 14, 2024 CAD ($) share $ / shares $ / Unit	Dec. 01, 2023 CAD ($) shares	Aug. 11, 2023 CAD ($)	Aug. 09, 2021 CAD ($) $ / shares	Apr. 30, 2024 CAD ($) share $ / shares shares	Nov. 24, 2023 CAD ($)	Sep. 28, 2023 CAD ($)	Jul. 25, 2023 CAD ($)	May 29, 2023 CAD ($)	Jan. 29, 2021 CAD ($) $ / shares	Nov. 30, 2023 CAD ($) share $ / shares	Nov. 30, 2022 share $ / shares	May 03, 2024 CAD ($)	May 01, 2024 CAD ($)	Apr. 11, 2024 CAD ($)	Apr. 11, 2024 USD ($)	Apr. 10, 2024 CAD ($)	Mar. 28, 2024 CAD ($)	Mar. 15, 2024 CAD ($)	Mar. 05, 2024 CAD ($)	Mar. 05, 2024 GBP (£)	Jan. 08, 2024 CAD ($)	Dec. 20, 2023 CAD ($)	Nov. 30, 2023 GBP (£)	Nov. 24, 2023 GBP (£)	Sep. 28, 2023 GBP (£)	Aug. 11, 2023 GBP (£)	Jul. 25, 2023 GBP (£)	May 29, 2023 GBP (£)
Disclosure of non-adjusting events after reporting period [line items]
Loans and receivables			$ 26,017			$ 17,749	$ 17,093	$ 60,151	$ 84,929		$ 209,702													£ 122,203	£ 10,000	£ 10,000	£ 15,000	£ 35,000	£ 50,000
Accrued interest											$ 3,765													£ 2,203
Price per unit issued				0.4						0.2
Proceeds from units issued | $				$ 2,300,000						$ 636,000
Weighted average exercise price of warrants granted											$ 0.1
Description of option to convert to equity			Company has the option to convert the full amount to 1.5% of the diluted share capital of the third party.			Company has the option to convert the full amount to 1% of the diluted share capital of the third party.	Company has the option to convert the full amount to 1% of the diluted share capital of the third party.	Company has the option to convert the full amount to 3.5% of the diluted share capital of the third party.	Company has the option to convert the full amount to 5% of the diluted share capital of the third party.
Number of options cancelled | share											3,900,000	125,000
Weighted average exercise price, cancelled											$ 0.66	$ 0.5
Subsequent Events [Member]
Disclosure of non-adjusting events after reporting period [line items]
Business advisory and consulting services, monthly compensation | $		$ 3,500
Number of restricted stock units | shares		1,560,000
Loans and receivables					$ 30,000								$ 20,000	$ 15,000	$ 9,636	$ 7,000	$ 20,000	$ 5,000	$ 5,000	$ 205,939	£ 120,000	$ 5,000	$ 5,000
Borrowings, interest rate					12%								10%	10%	10%	10%	10%	10%	10%			10%	10%
Accrued interest																				$ 6,360	£ 3,716
Number of units issued for private placement | share	10,000,000
Price per unit issued | $ / Unit	0.05
Proceeds from units issued | $	$ 500,000
Weighted average exercise price of warrants granted	$ 0.1
Description of option to convert to equity					The loan includes an option to convert into common shares of the Company equal to 100% of the principal amount of the loan plus all outstanding interest at the lowest price per share allowable under the policies of the CSE.
Issuance of loan bonus commons shares | shares					50,000
Number of options cancelled | share					200,000
Weighted average exercise price, cancelled					$ 0.05